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ABSTRACT 
Stimuli-responsive polymers have already showed tremendous promise in controlled and self-
regulated drug delivery. Successful construction of responsive polymers requires amalgamation 
of chemical, physical and biological principles. For careful therapy, a great deal of advantages 
offered by stimuli-responsive polymers is essential. A small or modest change in the 
environmental condition (e.g. temperature, pH, light) brings a sharp change in the properties of 
the responsive polymers. „Smart‟ drug delivery systems utilize these principles to mimic the 
biological response behavior to a certain extent. Synthetic polymers incorporated with stimuli-
responsive behavior would be amenable to overcome some of the systemic and intracellular 
delivery barriers. Development in material science has led to the engineering of variety of smart 
polymers which respond to diverse biological stimuli. 
The current research illustrates the development of two dual-stimuli-responsive polymers applied 
for local drug delivery. The polymers form thermogels at body temperature and degrade in either 
acidic or matrix metalloproteinase rich environments. The polymers were synthesized from 
Pluronic
®
 tri-block copolymers in two simple reaction schemes and thoroughly characterized for 
structures, physicochemical properties and cytotoxicity. The underlying principles involved in 
physicochemical behavior of polymers and polymer solutions were clearly discussed. The release 
characteristics of different therapeutic agents such as small molecule drugs, genes and proteins 
from the thermogels were investigated. Finally, to improve the release properties of small size 
proteins, a nanocomposite thermogel system was developed. The nanocomposite thermogel was 
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based on a nanoclay, laponite, and pH-sensitive thermogelling polymer. Finally, the 
nanocomposite thermogel incorporated with laponite sustained the release properties of small 
proteins comparing to regular thermogels. Taken all together, the novel thermosensitive 
polymers and nanocomposite thermogel system have great potential for bioresponsive local drug 
delivery where the amount of bioactive release entirely depends on physiological needs. 
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CHAPTER-1 
INTRODUCTION 
As newer drug entities continue to be evolved, more efficient and intelligent ways of delivering 
these drugs are also developed incessantly. For controlled and prolonged release of these drugs, 
delivery systems made of smart polymers were generated. Unlike the conventional drug delivery 
systems, the controlled delivery platforms are constructed to maintain the plasma drug 
concentrations in desired therapeutic range and localize the drug to a particular body 
compartment with a single dose. In order to apply the polymer therapeutic safely and confidently 
for drug delivery or tissue engineering, it has to comply with an extensive list of criteria. Most 
importantly, the polymer has to be water-soluble, non-toxic, non-immunogenic and 
biodegradable. If the polymer is non-degradable, care should be taken to engineer an optimum 
sized polymer which can be excreted safely to avoid accumulation in the body. If the polymer is 
degradable, the safety of the degraded products needs to be evaluated. 
Recently, many researchers started developing smart polymeric systems using stimuli-responsive 
polymers. Different names such as stimuli-responsive polymers, intelligent polymers, smart 
polymers, have been coined for synthetic polymers based on their chemical and physical 
properties. The stimuli-responsive polymers offer myriad of advantages for drug delivery where 
the responsive polymers become an active participant, rather than a passive vehicle, in the 
optimization of therapy. The responsive polymers often adopt a more active role such as 
releasing bioactives upon an external stimulus. The external stimulus results in an alteration of 
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polymer properties such as solubility, conformation, hydrophilic/lipophilic balance, degradation 
and ability to release a bioactive molecule. A combination of several responses is also likely at 
the same time. Therefore, the researchers are interested in constructing the polymer or polymeric 
systems responsive to one or more stimuli available in the nature. The drug delivery systems 
constructed using responsive polymers are divided into two major categories, viz. pulsed or 
externally regulated and closed-loop or self-regulated or internally regulated systems. The 
polymeric systems which respond to external stimuli such as temperature, pH, electric field, 
magnetic field, light, microwave radiation, ultrasound, etc., are considered as pulsed or 
externally regulated systems
1-5
. Similarly, the self-regulated systems will be controlled by the 
stimuli generated inside the biological system such as pH, temperature, enzyme concentrations, 
etc
6-8
. Although various responsive systems are reported in the literature, present discussion will 
be limited to temperature, pH and enzymatic-responsive systems.  
Temperature can be an external stimulus (i.e) generated artificially outside the body or an 
internal stimulus originating inside the biological system. The present discussion emphasizes 
mainly on in situ forming hydrogels based on temperature responsive polymers. These systems 
are fluids at room temperature which can be introduced into the body in a minimally invasive 
manner to gel at body temperature and also at desired location. These systems offer advantages 
such as lack of risk based surgical procedure for implantation and ability to incorporate various 
therapeutic agents by simple mixing. In addition, the systems show great flexibility in the 
architecture by taking the shape of the body cavity or the defect when injected into the body. 
Temperature responsive polymers have been gaining lot of attention as they don‟t use any 
organic solvents or copolymerization agents for gelation. It is worth mentioning about two 
important properties such as lower critical solution temperature (LCST) and upper critical 
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solution temperature (UCST) of the polymers
9
. LCST and UCST are characterized by the 
changes in the polymer solubility upon changing the temperature. The polymers, which become 
insoluble upon heating, show LCST, whereas reverse phenomenon holds good for polymers with 
UCST. The balance between hydrophilic and hydrophobic moieties in the polymer backbone, 
usually, governs the changes during LCST or UCST. The phase separation at this temperature is 
caused by the alteration of certain molecular interactions such as hydrogen bonds and 
hydrophobic interactions. For example, at the LCST, polymer-polymer and water-water 
interactions are more favorable comparing to the hydrogen bonding between polymer and water. 
The dominated „like-like‟ interactions, lead to the dehydration of the macromolecule which, 
finally, makes the molecular structure more hydrophobic. In case of amphiphilic polymers, the 
polymer-polymer interactions are responsible for micelle packing and gel formation when 
temperature is increased. Whatever may be the gelation mechanism, an ideal system should be a 
free flowing fluid below body temperature and gel quickly when injected into the body. In 
addition, these systems should not affect the healthy or unwanted tissue by changing the 
environment (e.g. alteration of the pH of the surroundings) near the injection location. The 
important classes of polymers that undergo sol-gel transition with temperature are poly(ethylene 
glycol-b-propylene glycol-b-ethylene glycol) (PEG-PPG-PEG) copolymers and its analogs, 
PEG/poly(D,L-lactide-co-glycolide) (PLGA) block copolymers and polypeptides/polypeptide-
based copolymers
10-12
. Among the fore-mentioned classes, PEG-PPG-PEG copolymers 
(Poloxamer or Pluronic
®
) have been studied extensively for the last few years
13
.  
1.1. Review of PEG/PPG based temperature-sensitive polymers 
Pluronic copolymers have surface active properties and have been used widely in pharmaceutical 
research for the last 15 years. Pluronic
® 
copolymers are non-ionic surfactants and consist of more 
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than 30 different polymers. These are ABA-type triblock copolymers composed of PEO and PPO 
blocks. Depending on the molecular weight and PEO to PPO block ratio, the polymers exist in 
different physical states such as liquids, pastes and flakes or solids. Molecular weight and PEO 
to PPO ratio of commercially available Pluronic
® 
copolymers vary from 1100 to 14000 and 1:9 
to 8:2 respectively. At an optimum concentration (critical gelation concentration) the polymer 
solution forms thermoreversible gel. The unique in situ gel-forming behavior of Pluronic
® 
copolymers particularly suited for the delivery of bioactive agents viz. small molecule drugs, 
proteins and genes. After administration into the body, Pluronic
®
 gels can protract the drug 
release compared to Pluronic
®
 solutions. Most release profiles show that the release from 
Pluronic
®
 based thermogels is restricted to several hours and rarely exceeded a few days. This 
particular property made Pluronic
®
 thermogels attractive for short-term therapies such as 
infection treatment, pain management and fertility control
14-18
. Apart from the parenteral route, 
other administration routes were also evaluated. Nasal, ophthalmic, transdermal, vaginal and 
rectal routes are the examples of other administration routes
19-26
. Rapid erosion of the gels 
restricted the use of Pluronic
®
 copolymers for long-term drug delivery. In addition to rapid 
erosion, Pluronic
® 
gels suffer from other drawbacks such as weak mechanical strength and non-
degradability. Particularly, the non-degradability and weak renal elimination restrict the use of 
high molecular weight Pluronic
® 
copolymers in the drug delivery. To circumvent the problems, 
new polymers have been synthesized by joining together several low molecular weight Pluronic
® 
units via biodegradable linkages
10,27
. Novel multiblock copolymers of Pluronic F127 have been 
developed by coupling Pluronic
®
 F127 monomers using hexamethylene diisocyanate or 
phosgene as the coupling reagent
28
. The viscosities of the new polymer solutions were nearly 15 
times higher than Pluronic
®
 F127 at body temperature. The oligomerization not only improved 
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the viscosities but also the release properties of the incorporated drug from the thermogel. The in 
vitro release of a model drug (RG-13577) from the thermogel lasted for over 40 days, in contrast 
to only seven days release from the thermogel at the same concentration. Ahn et al. developed a 
series of biodegradable multiblock copolymers coupling Pluronic
®
 P85 through terephthaloyl 
chloride
10
. Depending on the molecular weight of the multiblock copolymers (4000-40000 
g/mol), the gel duration lasted from several hours to several weeks. A class of new multiblock 
copolymers based on PEG-PPG was synthesized by attaching PEG and PPG using carbonyl 
chloride and diacyl chlorides as the coupling molecules
29
. The novel polymer solutions showed 
markedly higher viscosities comparing with Pluronic
®
 F127 solutions. Also, the alternating 
ether-carbonate bonds within the multiblock copolymer structure made the copolymers 
biodegradable. A series of pentablock copolymers was developed from grafting both ends of 
Pluronic
®
 F87 with Poly(D,L-lactic acid) (PLA) or Poly (ε-caprolactone) (PCL)30,31. In 
comparison with Pluronic
®
 F87, the pentablock copolymer showed lower critical micellization 
temperature (CMT). Also, importantly, the pentablock copolymers retained the thermoresponsive 
sol-gel transition behavior. A promising in vitro release of hydrophilic (procain hydrochloride) 
and hydrophobic drug (9-(methylaminomethyl) anthracene) molecules was observed from PLA6-
F87-PLA6 and PCL4-F87-PCL4 thermogels, respectively. Cohn et al. synthesized degradable 
Pluronic
®
-based poly(ether-ester-urethane) multiblock copolymers by coupling oligo(ester)-
Pluronic
®
 F127-oligo(ester) pentablock copolymers using hexamethylene diisocyanate 
(HMDI)
32
. By varying the polyester block length and the degree of the chain extension, the 
rheological properties and degradation behavior of the copolymer hydrogels were regulated. 
Recently, enzyme-mediated cross-linking micelles of Pluronic
®
 F127 were proposed for drug 
delivery and cell encapsulation
33
. Pluronic
®
 F127 was end capped with tyramine to induce 
6 
 
tyrosinase mediated cross-linking of Pluronic micelles. The enzyme mediated cross-linking 
produced high-strength injectable hydrogels, also, exhibiting temperature-responsive sol to gel 
behavior. The cross-linked gels showed enhanced mechanical strength comparing to unmodified 
Pluronic gels under physiological conditions. In addition, interestingly, the crosslinked micelle 
hydrogels released a macromer drug, fluorescein isothiocyanate–dextran (FITC-Dextran; 20 
kDa), for 12 days which is significantly higher than the release from the thermogels prepared 
from unmodified Pluronic
®
 F127. Chung et al. used another approach to enhance the gel stability 
and mechanical strength
34
. A series of multi-block Pluronic copolymers linked by D-
lactide and L-lactide oligomers were synthesized and blended to form stereo complexed 
hydrogels. The crosslinked hydrogels exhibited significantly lower critical gelation concentration 
(CGC) and critical gelation temperature (CGT) values, compared to uncomplexed multi-block 
copolymers. Finally, the stereocomplexed hydrogels were shown to release incorporated human 
growth hormone for 13 days by a mixed diffusion/erosion mechanism. Liu et al. introduced a 
thermosensitive hydrogel based on amphiphilic PCL-Pluronic-PCL block copolymers 
synthesized via radical polymerization
35
. Surprisingly, the block copolymers produced gel to sol 
transition as the temperature increased. The phenomenon was explained based on double layers 
shell/core structure of PCL–Pluronic–PCL micelles. Also, hydrophobic interactions and partial 
crystallization mechanisms were thought to play key role in the gelation. 
1.2. Review of PEG/Polyester based temperature-sensitive polymers 
Copolymers of PEG with hydrophobic aliphatic polyesters such as PLA, polyglycolide (PGA), 
PCL and PLGA have shown thermosensitivity in aqueous solutions. Nearly 15 years ago, first 
thermosensitive polymer of this class, PEG-poly(l-lactide)-PEG (PEG-PLLA-PEG), was 
reported by Jeong and his co-workers
6
. Initially, a diblock copolymer, monomethoxy PEG 
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(MPEG)-PLLA, was synthesized by ring-opening polymerization reaction between MPEG and l-
lactide. Later, the diblock copolymer was coupled using HMDI to generate PEG-PLLA-PEG. 
The triblock copolymer solution presented gel to sol transition upon increase in temperature and 
the gel to sol transition was dependent on PLLA block length. A similar triblock copolymer, 
PEG-PLA-PEG, was recently synthesized by replacing l-lactide with d,l-lactide (LA)
36
. Not 
surprisingly, the polymer solutions showed temperature dependent gel-sol transition. Gelation at 
low temperature was mainly due to hydrogen bonding between PEG blocks; whereas the high 
temperatures resulted in hydrogen bond breakage and gel to sol transition. In addition to linear-
block copolymers, star-block copolymer solutions were responsive to temperature. 
Biodegradabale star-shaped PLLA-PEG block copolymers were the main examples under this 
category
37,38
. Star-shaped polymers were the result of a coupling reaction between hydroxyl-
terminated 3-armed poly(l-lactide) and α-monocarboxy- ω- monomethoxy poly(ethylene oxide). 
Gelation of the polymer solutions was mainly attributed to micellar packing at low temperatures. 
However, at high temperatures, dehydration and contraction of PEO chains destroyed the 
micelle-packing and resulted in gel to sol transition. In addition, with increase in molecular 
weight of PLLA block and PEO block, the critical gel concentration decreased, the boundary 
curve shifted to the left, and the gel regions were expanded.  
The concept of designing block copolymers that undergo gel to sol transition is interesting. 
However, these systems have little clinical relevance, since the injections at elevated 
temperatures with respect to body temperature is quite uncomfortable for patients. To overcome 
the drawbacks associated with these systems, researchers introduced thermosensitive polymers 
that undergo sol to gel transition at or near body temperature. PEG-PLGA-PEG (ABA-type) 
triblock copolymers were developed for sol to gel transition at low temperatures
11
. In addition to 
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sol to gel transition, the polymer solutions underwent gel to sol transition at elevated 
temperatures. The gelation at low temperature was driven by micellar growth and close packing 
of micelles and the second thermal transition (gel to sol transition) at high temperatures was 
mainly due to breakage of micellear structure. The authors concluded that the gelation 
temperature could be adjusted by varying PLGA and PEG block lengths and PLGA composition. 
Another interesting triblock copolymer of this category was PLGA-PEG-PLGA (BAB-
type)
12,39,40
. Even though the architecture of the polymer was completely different from ABA-
type polymers, BAB-type polymers showed thermosensitive gelation. Also, the synthesis of 
BAB-type polymers was simpler comparing to ABA-type polymers, using HMDI as a coupling 
agent. Since BAB-type polymer has two hydrophobic PLGA end blocks, the gelation mechanism 
was different from ABA-type polymers. The BAB-type polymer formed micelles with 
intermicellar bridges, whereas the ABA-type polymer self assembled into regular micelles with 
hydrophobic core and hydrophilic shell, in aqueous solution. Below CGT, PLGA-PEG-PLGA 
polymers formed some bridging micelles, however, due to low hydrophobicity of PLGA 
segment, no gelation was noticed. With increasing temperatures to CGT, a bridged micelle 
network was formed because of increased hydrophobicity of PLGA blocks, leading to sol to gel 
transition. ReGel
®
 (PLGA-PEG-PLGA: 1500-1000-1500) was developed by Zentner et al. for 
long-term drug delivery applications
12
. At 23 wt%, the thermogels lasted for 6-8 weeks and ~4 
weeks, in vitro and in vivo respectively. Later, the researchers found that the graft polymers of 
PEG-g-PLGA and PLGA-g-PEG were superior to linear block copolymers (PEG-PLGA-PEG or 
PLGA-PEG-PLGA) in controlling the time of persistence of gels
41-43
. PEG-g-PLGA copolymer 
was synthesized by ring opening polymerization of LA and glycolide (GA) using a macro 
initiator (hydroxy-pendent PEG), whereas PLGA-g-PEG copolymer was prepared by a one-step 
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ring opening polymerization of LA, GA and epoxy-terminated PEG. The PEG-g-PLGA 
copolymer showed sol to gel transitions above 16 wt% in water and the thermogels lasted for 
only one week under physiological conditions. On the other hand, PLGA-g-PEG copolymers 
also presented sol to gel transitions upon a temperature raise. Interestingly, the thermogels (29 
wt%) of PLGA-g-PEG persisted for more than two months, a significant improvement 
comparing to one week persistent time observed for the PEG-g-PLGA copolymer thermogel. 
Authors investigated the gelation mechanism using 
13
C-nuclear magnetic resonance (
13
C-NMR) 
spectroscopy, rheology, infrared spectroscopy and small-angle neutron scattering and concluded 
that dehydration of PEG segments and micellar aggregation caused sol to gel transition
44
. PEG 
molecular weight and amount of PEG grafting were altered to obtain a gelation window suitable 
for physiological conditions. In addition, the gel duration (one week to three months) was 
completely optimized by mixing PEG-g-PLGA and PLGA-g-PEG in predetermined 
propositions. 
New group of block copolymers were studied by replacing hydrophobic moieties such as PLA, 
PGA and PLGA with a crystalline hydrophobic polymer- PCL
45-49
. Similar to previous 
polyesters, PCL was biocompatible and biodegradable. In addition, PCL copolymers offered a 
powdery morphology, making them easier to handle than other polyesters. A diblock copolymer, 
MPEG-PCL, was developed by activated ring opening polymerization between ε-caprolactone 
and MPEG and the molecular weights of the final polymers were controlled with feed ratio of 
reactants
48
. Aqueous solutions of MPEG-PCL exhibited gel to sol transition on temperature 
increase. The authors injected MPEG-PCL (MW 2000-2300 Da) aqueous solutions (23 wt%) into 
a rat and demonstrated the rapid gelation at body temperature. In vivo formed gels were 
maintained for 1 month with minimum inflammation at the injection site. Subsequently, the same 
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research group reported another set of MPEG-PCL copolymers with relatively low molecular 
weight MPEG (MW 750 Da) and PCL (MW 1400-3000 Da)
47
. Interestingly, the diblock 
copolymers were soluble in water at low temperatures and showed sol-to-gel-to-sol transition 
upon continuous temperature increase. The data suggested that the molecular weight of MPEG 
had a significant influence on the solubility of final polymer and the gelation pattern. Recently, 
Jeong et al. introduced PEG-PCL-PEG and PCL-PEG-PCL triblock copolymers and the aqueous 
solutions of the copolymers were soluble in water at low temperatures
45,46
. Further, the 
copolymer solutions showed clear sol-to-gel-to-turbid sol transition on temperature increase. An 
investigation into the gelation mechanism by dynamic light scattering and 
13
C NMR revealed 
that the sol to gel transition was driven by micellar aggregation and the gel to sol transition 
occurred due to breakage of core-shell structure. PCL-PEG-PCL was expected to be more 
crystalline comparing to PCL-PEG-PCL because of high PCL content. Even though PCL-PEG-
PCL solution (20 wt%) was a clear transparent solution, it turned turbid in 1 hour at 20 °C 
because of high crystallinity of the copolymer. More recently, poly(caprolactone-co-trimethylene 
carbonate)-PEG-poly(caprolactone-co-trimethylene carbonate) (PCTC-PEG-PCTC) was 
introduced to overcome the problems associated with the crystallinity of PCL fragment
49
. The 
triblock copolymer solution underwent sol to gel transition and produced very soft gel with a 
storage modulus (G‟) of 1 Pa. Moreover, the gels lasted for 50 days at 37 °C in phosphate buffer. 
The crystallinity of the final polymer was also dependent on the molecular weight of the PCL 
segment. Multiblock copolymers, (PCL-PEG-PCL)n, were synthesized by joining several units of 
PCL-PEG-PCL (1000-1000-1000) using terephthaloyl chloride
50
. Surprisingly, the multiblock 
copolymer solution at 20 wt% did not turn turbid at room temperature indicating that increase in 
molecular weight of the PCL fragment could decrease the crystallinity of final polymer. 
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Moreover, multiblock copolymer solutions produced softer gels (G‟: 100 Pa) comparing to 
triblock copolymer thermogels (G‟: 10000 Pa). 
In addition to the molecular weight, stereoisomeric aspects of lactide group play an important 
role in the physico-chemical properties of the final block copolymer
51-55
. To investigate this 
effect, multiblock copolymers of PEG/poly(d,l-lactide) (PDLLA) and PEG/PLLA with similar 
molecular weights were developed
52
. In comparison with PEG/PDLLA multiblock copolymer, 
PEG/PLLA multiblock copolymer showed a lower critical gel concentration, a lower sol-to-gel 
transition temperature, and a wider gel window. Also, at constant concentration, the maximal gel 
modulus of the PEG/PLLA multiblock copolymer was significantly high comparing to 
PEG/PDLLA multiblock copolymer. Extensive characterization revealed that that the differences 
in the thermogel properties come from lower dynamic molecular motion and the higher 
aggregation tendency of the PLLA due to the isotactic localization of the hydrophobic methyl 
groups rather than crystallization of PLLA. Fujiwara et al. utilized the stereo-complexing ability 
of enantiomeric triblock copolymers such as PLLA-PEG-PLLA and PDLA-PEG-PDLA, to 
induce sol-gel transition
51
. Since the individual block copolymers did not show thermal gelation, 
the main driving mechanism for sol to gel transition of the polymer mixtures was stereo-
complexation.  Another interesting criterion that influenced the thermal gelation was the end 
group modification of thermosensitive copolymers
56-59
. Jo et al. aliphatically modified the 
hydrophobic ends of poly(l-lactide-co-caprolactone)-b-PEG-b-poly(l-lactide-co-caprolactone) 
(PLLACL-PEG-PLLACL) with hexanoyl and lauroyl groups for effective modulation of the 
thermogelling properties
56
. Interestingly, the triblock copolymers acquired the thermogelling 
property after aliphatic modification. The results suggested that the 
hydrophilicity/hydrophobicity of a polymer could be adjusted by a careful terminal modification. 
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Terminal group modifications using various other end caps (hydroxyl, acetyl, propionyl and 
butanoyl groups) for PLGA-PEG-PLGA triblock copolymers have been reported
58,59
. In 
summary, individual block length, molecular weight of the final polymer, polymer topology, 
polymer concentration and end groups affected one or more of the polymer physical properties 
such as aqueous solubility, gelation, gel modulus, kinetics of gelation and gel duration. 
1.3. Review of polypeptide-based temperature-sensitive polymers 
Research has been directed towards engineering novel thermosensitive materials with 
biocompatible and biodegradable polypeptide backbones
60-62
. The ability of these materials to 
self assemble into ordered structures (α-helix, β-sheet and random coil) makes them more 
interesting. Polypeptides of triple-helix-forming collagen model peptide, (Pro-Hyp-Gly)10, and 
thermosensitive elastin-derived pentapeptide, Val-Pro-Gly-Val-Gly, showed inverse phase 
transition from transparent solution to turbid suspension upon increasing  the temperature
63
. 
Moreover, the polypeptides with more (82–86 mol %) Val-Pro-Gly-Val-Gly content showed 
reversible gel formation, indicating that (Pro-Hyp-Gly)10 acts as a hydrated unit and Val-Pro-
Gly-Val-Gly acts as a thermosensitive crosslinking point. Triblock copolymers consisting of 
elastin-like protein sequences (Val-Pro-Gly-Val-Gly repeats), hexahistidine metal-binding motifs 
and hydrophobic end blocks, [(Ile-Pro-Ala-Val-Gly)4(Val-Pro-Ala-Val-Gly)]n, were developed 
for heavy metal removal applications
64
. Even though the system was not designed for drug 
delivery, the polymer solution (6 wt%) turned to a gel at 25 °C, suggesting potential applications 
in drug delivery. Pochan et al. designed a de novo-peptide, MAX3, with thermosensitivity
65
. The 
polypeptide in aqueous solution (2 wt%) turned from random coil to β-hairpin structure to 
generate a strong gel network (G‟: 1100 Pa) at 75 °C. Another interesting diblock copolypeptide, 
consisting of hydrophobic and charged blocks showed thermosensitivity
60
. The polypeptide 
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solution turned to gel at elevated temperatures and the gelation was mainly due to ordered 
packing of α-helical and β-strand segments and association of the hydrophobic domains. In 
another study, physically crosslinked poly(amino acid) hydrogels were developed by a sol–gel 
transition of amphiphilic poly(N-substituted α/β-asparagine)s in an aqueous solution66. Thermal 
gelation was achieved by the introduction of alkyl groups into the backbone of poly(N-
substituted α/β-asparagine)s to optimize the hydrophobicity of the polymer. Thermal gelation 
was also evident in aqueous solutions of l/dl-polyalanine block copolymers
67
. Such polymers 
were developed for successful chondrocyte three-dimensional culture. The population and 
thickness of fibrous nanostructure of the hydrogel were dependent on the fraction of β-sheet 
structure of polyalanine. In addition, the nanostructure of the hydrogel controlled the 
proliferation and protein expression of encapsulated chondrocytes. 
Novel thermosensitive polymers were developed by conjugating synthetic polymers such as 
PEG, PEG-PPG-PEG, poly(2-hydroxypropyl methacrylamide), polystyrene, etc. with functional 
polypeptides
7,68-71
. Conjugation of PEG with enzymatically degradable poly(alanine-co-phenyl 
alanine) (PAF) resulted in thermosensitive PEG-PAF for biomedical applications
7
. Interestingly, 
PEG-PAF showed thermal gelation at very low concentrations (3.0-7.0 wt%) in aqueous 
solutions. Fourier transform infrared spectroscopy (FTIR), 
13
C-NMR and rheology data 
suggested that the sol to gel transition was mainly due to PEG-PAF conformational change to β-
sheet from random coil. Jeong et al. modified the terminal groups of amphiphilic PEG-PPG-PEG 
copolymers with polypeptides such as poly(Ala-co-Phe), Arg-Gly-Asp, poly(Ala-co-Leu) and 
l/dl-poly(Ala)
69,72-74
. Thermosensitive Pluronic
®
 F68 copolymer consisting of a hydrophobic 
unit, oligo-LA/oligo-CL, and a cell-adhesive peptide, Arg-Gly-Asp, was investigated for drug 
delivery and tissue engineering applications
72
. Modified Pluronic
®
 F68 showed gel-to-sol-to-gel 
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transition and the gelation properties were affected by chain length of oligo-LA/oligo-CL, and 
the concentration of the polymer solutions. PEG-PPG-PEG triblock copolymers with different 
molecular weights (600 and 900 Da) and PEG/PPG ratios (~2.4 and ~4.4) were end-capped with 
l/dl poly(Ala) for variable gelation properties
69
. Structure-property relationship data suggested 
that the sol to gel transition temperature of the polymer solutions decreased with increased PA 
block length, decreased PEG-PPG-PEG length and increased l-Ala/dl-Ala ratio. Recently, the 
same research group modified the end blocks of PEG-PPG-PEG triblock copolymers with 
poly(Ala-co-Phe) and poly(Ala-co-Leu)
73,74
. Both polymers showed sol to gel transition in the 
concentration and temperature range 3.0-10.0 wt% and 10-50 °C, respectively. Random coil to β-
sheet conformational change of the polymers was considered to be the gelation mechanism in the 
aqueous solution. Thermogles of poly(Ala-co-Leu) end-capped polymers were specifically 
degraded in presence of matrix metalloproteinase and elastase, showing high sensitivity towards 
proteolytic enzymes. 
1.4. Organization of the thesis 
Chapter 2 discusses the synthesis of Pluronic
® 
based multiblock copolymers prepared via pH-
sensitive acetal linkages. Also, the extensive characterization of polymers using several 
physicochemical characterization techniques (NMR, gel permeation chromatography (GPC), 
differential scanning calorimetry (DSC), circular dichroism (CD), etc.) has been provided in this 
chapter. pH is an important indicator, which can be used as a stimulus for pH-responsive 
polymers. The pH profile of different tissues and cellular compartments varies differently. Blood 
(pH 7.35-7.45), stomach (pH 1.0-3.0), duodenum (pH 4.8-8.2), colon (pH 7.0-7.5), early 
endosome (pH 6.0-6.5), late endosome (pH 5.0-6.0), lysosome (pH 4.5-5.0) and golgi (pH 6.4) 
have different pH conditions. Not only the pH conditions of healthy tissues but also the pH of 
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pathological tissues, such as upon acquisition of inflammation, infection and cancer (pH 6.5- 7.4) 
vary prominently. Therefore, the changes in the pH conditions have been the basis for the 
construction of current pH-responsive polymers. Figure 1 clearly shows the concept of thermogel 
formation and drug release in low pH conditions. 
 
Figure 1: Schematic representation showing thermogel formation at body temperature followed 
by polymer degradation and drug release in acidic conditions. 
Chapter 3 discusses drug release from pH-sensitive thermogels for different therapeutics agents. 
In addition, extensive characterization for drug loaded polymer solutions has been reported.  
Chapter 4 reports a nanocomposite thermogel (NCT) comprising pH-sensitive polymer and a 
synthetic nanoclay (laponite) for sustained release of small proteins.  
The discussion in Chapter 5 is based on Pluronic
® 
multiblock copolymers synthesized via 
matrix metalloproteinase (MMP)-sensitive peptide linkages. MMPs play a critical role in tumor 
progression, angiogenesis and metastasis. Particularly, MMP 2 and 9 which degrade extracellular 
matrices have been known to be overexpressed in many types of cancers. 
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Figure 2: Schematic representation showing thermogel formation at body temperature and 
bioresponsive drug release in response to MMP levels. 
The current polymers were designed to respond to MMPs overexpressed in the cancers. Figure 2 
portrays the concept of thermal gelation and MMP-dependent degradation of the polymer and 
drug release. 
Chapter 6 summarizes the entire research work. 
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CHAPTER-2 
pH-SENSITIVE THERMOGELLING POLYMER FOR DRUG DELIVERY 
2.1. Abstract 
A class of thermosensitive biodegradable multiblock copolymers (MBCPs) with acid-labile 
acetal linkages were synthesized from Pluronic
®
 triblock copolymers (Pluronic
®
 P85 and P104) 
and di-(ethylene glycol) divinyl ether. The novel polymers were engineered to form thermogels 
at body temperature and degrade in acidic environment. The Pluronic
®
-based acid-labile 
polymers were characterized using NMR, GPC and DSC. In vitro biocompatibility of the 
synthesized polymers was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay.  The polymers showed reverse thermogelling behavior in water around 
body temperature. The sol-gel transition temperatures of the polymers synthesized from 
Pluronic
®
 P85 and P104 were lowered from 70.3 to 30 
o
C and from 68.5 to 26.9 
o
C, respectively, 
when the synthesized polymers were compared with corresponding Pluronic
®
 block copolymers 
at a concentration of 25 wt%. The hydrophobic dye solubilization confirmed the formation of 
polymeric micelles in the aqueous solution. The sizes of multiblock copolymer increased upon a 
temperature rise indicating that thermal gelation was mediated by micellar aggregation. The 
novel polymers hold great potential as a pH-sensitive controlled drug delivery system due to 
their interesting phase transition behavior and biocompatibility. 
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2.2. Introduction 
Recent advances in smart polymeric materials have brought a great promise for the development 
of bioresponsive drug delivery systems which are able to release therapeutic molecules in 
response to the signals stemming from diseased tissues
75,76
. Especially, biodegradable polymers 
which respond to temperature have been extensively considered as an effective injectable 
biomaterial for the delivery of small molecule drugs, proteins and genes
6,77-81
. These polymers 
are uniquely suited to minimally invasive therapeutic interventions by providing free flowing 
liquids below body temperature which turn into in situ gels upon injection
12,43
.  
More recently, dual-stimuli-sensitive polymers with thermosensitivity have been evolved
76,82-84
. 
Poly(2-diethylaminoethyl-methyl methacrylate)-PEG-PPG-PEG-poly(2-diethylaminoethyl-
methyl methacrylate), a pentablock copolymer which is pH-sensitive thermogelling polymer has 
been synthesized from Pluronic
®
 F127 triblock copolymers via controlled atom transfer radical 
polymerization
82
. The pentablock copolymer exhibits pH-sensitive micellization and 
thermoreversible sol-gel transitions in water. Poly(β-amino ester) has also been used as a duo-
functional group in the synthesis of poly(β-amino ester)-PCL-PEG-PCL-poly(β-amino ester), a 
thermosensitive pH-sensitive pentablock copolymer
83
. The pentablock copolymer was 
synthesized by the coupling of pH-sensitive poly(β-amino ester) to thermosensitive 
biodegradable PCL-PEG-PCL. An interesting dual-stimuli-sensitive polymer has been based on 
acid-labile acetal linkages which have provided an effective mechanism of polymer 
biodegradation in an acidic medium
85
. Polyacetal-based temperature/pH-sensitive polymers were 
synthesized by grafting PEG to a polyacetal backbone
84
. The PEG-grafted polyacetal has formed 
a thermogel which favorably erodes at an acidic pH. Another thermosensitive polymer with dual 
sensitivity has been introduced by the incorporation of bioreducible disulfide bonds in the 
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polymer backbone
76
. These dual sensitive polymers are advantageous over other thermosensitive 
polymers in that the release of a pharmacologically active agent can be triggered by an acidic 
milieu of a diseased tissue or intracellular compartments. The specific pH for the degradation of 
acetal-based polymers can be found in extracellular tumor fluid (pH 6.5 - 7.2) and endosomes 
(pH 5 – 6.5) which is lower than the pH of the normal tissues86-90. 
Even though a variety of dual-stimuli-sensitive polymers have been reported, their syntheses 
usually require complicated multi-step reactions
82,83
.  In addition, the responses of the polymers 
to each stimulus are usually slow because of the chemico-structural restrictions for the dual 
sensitivity
84,85
. The purpose of this study is to synthesize novel Pluronic
®
-based multiblock 
copolymers connected via acid-labile acetal bonds rendering facilitated pH-sensitive 
biodegradation. The hypothesis behind this novel polymer is that the combination of 
thermosensitive Pluronic
®
 and acid-labile acetal linkages would result in a dual-sensitive 
polymer which can form gel at body temperature and allow bioresponsive polymer degradation 
at an acidic pH.  In this body of work, we demonstrated the acid-catalyzed degradation of the 
polymers. 
2.3. Experimental 
2.3.1. Materials 
Pluronic
®
 P 85 and P104 were kindly provided from BASF Chemical Company (Florham Park, 
NJ). Polystyrene standards of molecular weights 1, 4, 20, 50 and 100K were obtained from 
Polysciences, Inc. (Warrington, PA). p-Toluenesulfonic anhydride, anhydrous tetrahydrofuran 
(THF), 1, 6-diphenyl-1, 3, 5-hexatriene (DPH) and anhydrous toluene were purchased from 
Acros Organics (Morris Plains, NJ). Di-(ethylene glycol) divinyl ether (DEGDVE) was obtained 
from Aldrich (Milwaukee, WI). FITC-Dextran of molecular weight 40kDa was purchased from 
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Sigma (Saint Louis, MO). Petroleum ether and methylene chloride from Fisher (Pittsburgh, PA) 
were of analytical grade and used as supplied.  
2.3.2. Polymer synthesis 
Fifteen grams of Pluronic
®
 P85 (MW 4600) or P104 (MW 5900), and 0.03 molar equivalent of 
p-toluene sulfonic anhydride to Pluronic
®
 were dissolved in 150 mL of anhydrous toluene. The 
mixture was dried by distilling off 100 mL of toluene. DEGDVE was added to the dry mixture at 
a 1:1 molar ratio to Pluronic
®
. The reaction was carried out overnight by magnetic stirring at 50 
o
C under dry nitrogen. Upon completion of the reaction, the reaction solution was mixed with 
150 mL of petroleum ether to precipitate polymer. The polymer precipitate was dissolved in a 
dilute sodium hydroxide solution at a 2:1 molar ratio of NaOH to p-TSA to achieve a 
concentration of 15 wt% at 4 
o
C. The aqueous polymer solution was heated to 75
o
C to precipitate 
the polymer. After dissolving the crude precipitated polymer in distilled water at a concentration 
of 20 wt%, the polymer was precipitated again by heating. The polymer was purified by another 
cycle of dissolving by cooling and precipitation by heating. The final precipitate was freeze-dried 
to obtain white powder. Two different thermosensitive Pluronic
®
-based MBCPs, MBCP-1 from 
Pluronic
®
 P85 and MBCP-2 from Pluronic
® 
P104, were finally obtained. The yields of the 
reactions were 90% and 87%. 
2.3.3. Polymer characterization  
Chemical structures of the synthesized polymers were analyzed by 
1
H-NMR. Polymers were 
dissolved in CDCl3 and recorded on a 400MHz NMR spectrometer (Bruker Ultrashield
TM
 400 
PLUS, Germany). Molecular weights of the synthesized MBCPs and Pluronic
®
 copolymers were 
determined by GPC. GPC was run on a Waters system equipped with a binary pump (Waters 
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1525), a refractive index detector (Waters 2414), and a Styragel HR4E column (300 × 7.8 mm 
I.D., 5 µm particle size). Tetrahydrofuran (THF) as a mobile phase was eluted at a flow rate of 
1.00 mL/min at 25 
o
C. Polystyrene standards in the molecular weight range of 4,000-100,000 
Daltons were also run to obtain a calibration curve. Molecular weights of the synthesized 
polymers were calculated from the obtained calibration curve. Melting temperatures of the 
synthesized polymers were determined by DSC. Thermograms were obtained by running the 
polymer samples sealed in aluminum pans on a Diamond DSC (Perkin Elmer, Waltham, MA)  in 
the temperature range of -30 to 100 
o
C with a heating and cooling rate of  5 
o
C/min. Initially the 
samples were equillibriated at -30 
o
C for 15 min. Dry nitrogen was continuously supplied at a 
flow rate of 20 mL/min during the analysis.  
2.3.4. Critical micelle concentration (CMC) of MBCP 
The CMCs of MBCPs were determined by a dye solubilization method with 1, 6-diphenyl-1, 3, 
5-hexatriene (DPH) 
10
. DPH of 0.4 mM in methanol was used in this CMC determination. Stock 
solutions of MBCP-1 and -2 were prepared at a concentration of 10 wt%. Polymer solutions in 
the concentration range of 10.0 to 1.0 × 10
-5
 wt% were prepared by serial dilutions of the stock 
solutions. Then, 25 µL of the DPH solution was added to 2.5 mL of each polymer solution. The 
polymer solutions were incubated for 24 h in a dark place. The absorbencies of the test solutions 
were recorded on a Lambda EZ201 UV spectrophotometer (Perkin Elmer, Waltham, MA) at 
wavelengths 377 and 391nm. 
2.3.5. Degradation of MBCP 
The MBCP solutions were prepared at a concentration of 25 wt% in deionized water. The 
polymer solution (100µL) was placed in 1mL vials and the vials were kept at 4 
o
C overnight. 
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Later, the polymer solutions were incubated at 37 
o
C for 15 min for gelation. After gelation, 
200µL of phosphate buffer (pH 5.0, 6.5 and 7.4) was added to the vials. After gel degradation for 
a predetermined time, the gels were frozen and lyophilized for GPC measurements. The dried 
polymer was dissolved in 1ml dichloromethane and centrifuged at 10000 rpm for 10 min to 
remove the buffer components. The supernatants were collected and vacuum dried to prepare 
GPC samples. GPC was run to determine the distribution of polymer molecular weight. 
2.3.6. In vitro cytotoxicity of MBCP 
Calorimetric MTT assay was used to test the cytotoxicity of MBCP-1 and MBCP-2 on NIH 3T3 
mouse embryonic fibroblast cells which have been widely used for the evaluation of in vitro 
biocompatibility of biomaterials
91-93. Initially, NIH 3T3 cells were cultured in Dulbecco‟s 
Modified Eagle‟s Medium (DMEM) supplemented with 10 % fetal bovine serum (FBS) and 
antibiotics. The cultured cells were seeded in 96 well plates at a density of 5 × 10
3
 cells/well in 
0.2 ml of the cell culture medium and grown for 24 h at 37 
o
C. After removing the culture 
medium, 100 µl of an MBCP solution of which concentration ranged from 0.1 to 5.0 % (w/v) in 
DMEM supplemented with 10 % FBS were placed on the top of the cell layer. The cells were 
incubated for an additional 48 h and the metabolic activity of the cells was measured. After 
removal of the test solution, 100 µl of fresh culture medium containing 50 µg MTT was added to 
each well and the cells were incubated for 4 h. Lysis buffer comprising of 10 % (w/v) sodium 
dodecyl sulfate and 45 % (v/v) dimethyl formamide was then added and incubated for another 24 
h. Absorbance was measured at 590 nm on a Model 550 microplate spectrophotometer (Bio-Rad, 
Laboratories Inc., Hercules, CA). Cell viability was calculated as compared to phosphate 
buffered saline (PBS)-treated cells (100 % survival). 
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2.3.7. Dynamic light scattering (DLS) 
The apparent particle sizes and particle size distributions of the MBCPs were measured using 
DLS. A concentration (4% w/v) above CMC was chosen to study the micellar aggregation as a 
function of temperature. Zetasizer Nano S (Malvern Instruments, Malvern, UK) was used to 
measure the particle size of the samples. The instrument was operated at four different 
temperatures such as 10, 20, 30 and 40 
o
C. 
2.3.8. Thermal gelation of MBCP solutions 
2.3.8.1. Test tube inverting method  
A series of MBCP solutions at concentrations of 5, 10, 15, 20 and 25 wt% were prepared in 
deionized water. One milliliter of each polymer solution was transferred to each 4mL vial and 
the vials were kept at 4 
o
C overnight. The vials were then placed in a water bath and equilibrated 
at 15 
o
C for 15 min. The sol-gel and gel-sol phase transitions of the polymer solutions were 
tested by tube inversions in the temperature range of 15 to 80 
o
C while heating the polymer 
solutions at a rate of 2 
o
C per every 5 min
11,42,56,76
. The temperature at which a polymer solution 
stopped flowing upon a tube inversion was recorded as gelation temperature. Phase transitions of 
the solutions of Pluronic
®
 P85, Pluronic
®
 P104, MBCP-1 and MBCP-2 were determined by the 
method. 
2.3.8.2. Falling ball method 
The solutions of MBCP-1 and MBCP-2 were prepared at a concentration of 25 wt% in 
deinonized water. One milliliter of each polymer solution was placed in a NMR tube with a 
diameter of 4.0 mm. The time (t) required for a steel ball (diameter (D) =1.97 mm, density (ρs) = 
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7.97 g/mL) to fall a specified distance (d = 3 cm) was measured with a temperature increment of 
2 
o
C per step for each polymer concentration. The polymer solutions were equilibrated for 20 
min at each temperature. A graph was plotted between temperature and the dynamic viscosity. 
The velocity of the falling ball (v) can be calculated from the formula d/t. The density of the 
polymer solution (ρf) was assumed to be 1.0 g/cm
3
. The specific gravities of the sphere (γs) and 
the polymer solution (γf) were calculated using the formula γ = ρg (acceleration due to gravity 
(g) = 980 cm/s
2
). Finally the dynamic viscosity (µ) was calculated using the following formula 
µ = (γs - γf) D
2
/ (18v) 
2.4. Results & Discussion 
A facile approach to engineer a pH-sensitive thermogelling multiblock copolymer has been 
demonstrated in this research work.  Pluronic
®
 (P85 and P104), a group of triblock copolymer of 
PEG-PPG-PEG, has been used for the synthesis of acid-labile thermosensitive biodegradable 
MBCPs. Figure 3 shows the synthetic reaction between Pluronic
® 
copolymer and DEGDVE in 
presence of p-toluenesulfonic anhydride as a catalyst, which results in MBCP with acetal 
linkages. The reaction requires anhydrous conditions because a trace amount of water leads to a 
premature termination of the oligomerization, which results in low molecular weight MBCP
85
. 
Water molecules are known to compete with hydroxyls to form hemiacetal intermediates. Hence, 
the reactants were azeotropically dried to remove water adsorbed on Pluronic
®
 prior to 
oligomerization. Polyacetal formation between divinyl ether and hydroxy-terminated monomers 
is favorable even at mild temperature
94-96
. 
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Figure 3: Synthetic reaction scheme for the preparation of MBCPs from PEG-PPG-PEG 
triblock copolymer (Pluronic
®
). 
At around 40C, the polymerization is completed within 1 h. However, we have reacted 
Pluronic
®
 and DEGDVE overnight at 50C to ensure a successful oligomerization because 
Pluronic
®
 of molecular weight around 5000 may not be readily accessible for the 
oligomerization. Thickening of the reaction mixture was observed in 4-5 h after the addition of 
DEGDVE. Upon completion of the oligomerization, p-TSA was immediately neutralized by 
dissolving the resulting polymer in a dilute sodium hydroxide solution in order to prevent 
polymer degradation by acid-catalyzed hydrolysis during purification. 
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Figure 4: Gel permeation chromatograms of (a) MBCP-1, (b) Pluronic
®
 P85, (c) MBCP-2 and 
(d) Pluronic
®
 P104. The retention times of the synthesized polymers (~8.1) were different from 
the Pluronic
® 
copolymers (~9.2) indicating the formation of MBCPs. 
MBCPs were precipitated by heating the solution to 70C. The polymers could be further 
purified in a complete aqueous environment by the cycle of cooling and heating, which would be 
advantageous for pharmaceutical applications of the polymers because harmful organic solvents 
can be avoided during the purification process. 
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Figure 5: Gel permeation chromatograms of MBCP-2 (a) after the synthesis, (b) after the 
purification in aqueous NaOH and (c) after the purification in water. 
In addition, unreacted Pluronic
®
 and DEGDVE could be removed by the polymer purification 
method. As shown in Figure 4, purified MBCPs include only trace amounts of the unreacted 
Pluronic
® 
copolymers. Moreover, GPC chromatographs in Figure 5 shows that the purification 
process removed most of the remaining Pluronic
®
. Chromatograph of crude MBCP right after 
synthesis indicates that the crude polymer contains a significant amount of unreacted Pluronic
® 
(Figure 5a). However, the purification of the crude polymer via repetitive precipitation in hot 
water was able to remove most of free Pluronic
® 
(Figure 5c). 
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Figure 6:  
1
H-NMR spectrum of MBCP-1. A quartet (d) at 4.75 ppm from acetal groups and a 
doublet (e) at 1.30 ppm from methyl protons of acetal groups indicated successful synthesis of 
MBCPs. 
Chemical structures of the synthesized MBCPs were confirmed by NMR spectroscopy. The 
1
H-
NMR spectra of Pluronic
®
 P85 and P104 and their multiblock copolymers were obtained in 
CDCl3. A typical 
1
H-NMR spectrum of MBCP is shown in Figure 6. This NMR spectrum of 
MBCP-1 shows methyl protons of PPG (-CH2CH (CH3) O-) at 1.0-1.2 ppm, methylene and 
methine protons of PPG (-CH2CH (CH3) O-) at 3.2-3.6 ppm, and methylene protons of PEG (-
CH2CH2O-) at 3.6 ppm. The acetal bond formation was confirmed by a quartet at 4.75 ppm 
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assigned as methine protons of acetal groups and a doublet at 1.30 ppm from methyl protons of 
acetal groups. The characteristic NMR peaks of acetal groups are consistent with previously 
reported results
85
. In the case of divinyl linkers, hydrophobic linkers such as butanediol divinyl 
ether and cyclohexane dimethanol divinyl ether would replace hydrophilic DEGDVE. However, 
the incorporation of hydrophobic linkers between hydrophilic PEG blocks of Pluronic
®
 would 
result in different gelation behavior from the MBCP synthesized with DEGDVE. 
The synthetic method demonstrated in this work is simple compared to previous syntheses for 
pH-sensitive thermogelling polymers. Previous synthesis of pH-sensitive thermogelling polymer 
involved multi-step reactions that included polyacetal synthesis and following PEG grafting
84
. 
Gel permeation chromatography was used to determine the number-average molecular weight 
(Mn) and polydispersity index of Pluronic
®
 copolymers and MBCPs. These values are 
summarized in Table 1. The calculated molecular weights of MBCP-1 and MBCP-2 were 36920 
(±1650) and 40210 (±860) g/mol, respectively. The GPC measurements also indicate that the 
synthesized polymers are multiblock copolymers with 4.9 and 4.1 Pluronic
®
 units in MBCP-1 
and MBCP-2 respectively. 
The reasons for the relatively low molecular weight oligomers may be the presence of trace 
water even after azeotropic distillation and limited availability of end hydroxyl groups of large 
Pluronic
®
 molecules for the oligomerization. Based on DSC analysis, melting temperatures (Tm) 
of Pluronic
®
 have been changed after the oligomerization in the presence of DEGDVE. Tm 
values of MBCP-1 and MBCP-2 were 29.0 
o
C and 29.8 
o
C respectively while Pluronic
®
 P85 and 
P104 have Tm values of 38.9 
o
C and 39.4 
o
C respectively. 
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Table 1: Characterization results of the synthesized MBCPs. 
 
 
 
 
 
a
 Number average molecular weights determined by GPC 
b
 Polydispersities  based on GPC measurements 
c  
Melting temperatures determined by DSC 
d,e
 Molecular weights from BASF chemical company 
 
The changes in Tm might be the result of interrupted polymer packing by the addition of acetal 
bonds between PEG blocks of Pluronic
®
. CMCs of MBCP-1 and MBCP-2 were determined by a 
hydrophobic dye solubilization method which has been frequently employed for the 
characterization of amphiphilic block copolymers
10
. DPH, a hydrophobic dye used in this study, 
has a tendency to partition into the hydrophobic core of the micelles in the presence of 
amphiphilic block copolymers. The solubility and UV absorbance of DPH sharply increase at the 
CMCs of the amphiphilic polymers. The CMCs of amphiphilic block copolymers can be 
calculated by extrapolating the absorbance versus logarithmic concentration (Figure 7). 
 
Polymer 
 
Mn (g/mol) 
a
 Mw/Mn 
b
 
Number of 
repeating units 
Tm (
 o
C)
c
 
Pluronic
®
 P85 7500 (4600
d
) 1.04 - 38.9 
Pluronic
®
 P104 9800 (5900
e
) 1.04 - 39.4 
MBCP 1 37000 1.8 4.9 29.0 
MBCP 2 40000 1.77 4.1 29.8 
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Figure 7: Determination of CMC of the synthesized MBCPs by the dye solubilization. The 
difference in the absorbance of DPH at 377 and 391nm was plotted on vertical axis. The cross-
section point of the two exponential lines was defined as the CMC. The CMCs of MBCP-1 and 
MBCP-2 were 2.854 (± 0.030) wt% and 0.485 (± 0.009) wt%, respectively. 
The CMCs of MBCP-1 and MBCP-2 were found to be 2.854 (±0.030) wt% and 0.485 (±0.009) 
wt%, respectively. The CMC difference between MBCP-1 and MBCP-2 is due to the difference 
in the ratio between hydrophobic PPG and hydrophilic PEG. MBCP-2 was expected to have a 
lower CMC than MBCP-1 because Pluronic
® 
P104 has a greater PPG/PEG ratio than Pluronic
®
 
P85. In the case of amphiphilic block copolymers based on PEG and PPG, a block copolymer 
with a greater PPG/PEG ratio generally has a lower CMC 
97
. 
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Figure 8: In vitro cytotoxicity of the synthesized MBCPs as a function of copolymer 
concentration. Cell viability was determined by an MTT assay using cultured NIH 3T3 mouse 
embryonic fibroblast cells. The results represent the means  SD for n=3. 
Cytotoxicity of the synthesized MBCPs has been evaluated by an MTT assay using NIH 3T3 
mouse embryonic fibroblast cells. The MTT assay was performed in the concentration range 0.1 
to 5.0% (w/v) and these results are shown in Figure 8.  It was difficult to perform the assay 
above 2.5% (w/v) polymer concentration because of pronounced polymer aggregate formation at 
37 
o
C. During the experiment, the removal of polymer aggregates via pipetting resulted in a 
slight suction of testing cells, which might cause an underestimation of cell viability. Even with 
the presumed underestimation of cell viability, MBCP solutions showed overall cell viability 
greater than 80%. In addition, thermal gelation of MBCP is not expected to leave a significant 
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amount of the polymer as unimers or micelles only which can penetrate cell membrane and thus 
affect cell viability.  Taken together, the synthesized MBCPs are not considered as cytotoxic and, 
as such, hold great potential for biomedical and pharmaceutical applications. It is vital that 
polymer degradation products should also be non-toxic. Degradation of acetal bond yields an 
equal amount of acetaldehyde
85
. Due to very low amount of degraded products compared to the 
initial polymer, the cytotoxicity associated with the degraded products, is expected to be 
minimal. Phase transitions of aqueous solutions of Pluronic
®
 copolymers and MBCPs were 
evaluated by a test tube inverting method. The sol-gel transitions of the polymeric solutions were 
determined by flow (sol) – no flow (gel) basis. Aqueous solutions of both MBCPs underwent 
sol-gel and gel-sol phase transitions upon temperature increments. As shown in Figure 9, the 
temperatures at which the phase transitions occurred were dependent on polymer concentration. 
Aqueous solutions of MBCPs were transparent at room temperature and turned into gels within 
two minutes as the temperature reached 30-37 
o
C. These MBCP solutions in sol phases were free 
flowing liquids which could be injected through a 25-gauge needle. The immediate thermal 
gelation of the MBCP solutions around body temperature and their injectability via a small-bore 
needle make MBCPs particularly attractive for local drug delivery. Even though several 
mechanisms have been proposed for the description of thermal gelation of block copolymer 
solutions, the mechanism based on ordered micelle packing has been most widely accepted
9,98,99
. 
Based on the ordered micelle packing mechanism, PPG blocks are dehydrated at a concentration 
above CMC and Pluronic
®
 block copolymers form micelles. At this concentration, polymeric 
unimers and the micelles are in an equilibrium state. As the temperature increases, this 
equilibrium shifts from unimers to micelles, making the micelle volume fraction (Фm) 
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considerably high. When Фm is greater than 0.53 in the case of Pluronic
®
, micelles come into 
contact and pack themselves into ordered structures leading to gelation 
100
. 
 
 
 
 
 
 
 
 
 
Figure 9: Phase diagrams of the aqueous solutions of Pluronic
® 
P85, Pluronic
® 
P104, MBCP-1 
and MBCP-2 determined by the test tube inverting method. 
Thermal gelation of MBCP solutions may be explained by the micelle packing. The solutions of 
Pluronic
®
 P85, MBCP-1 and MBCP-2 showed sol-gel-sol phase transition in a concentration 
range up to 25 wt%. However, 25 wt% Pluronic
®
 P104 solution possessed two distinct gel 
phases upon sol-gel-sol-gel transition. The first gel phase of Pluronic
®
 P104 solution ranged 
from 24 to 47 
o
C while the second phase ranged from 70 to 80 
o
C. This may be due to the 
formation of different liquid crystalline phases, isotropic/cubic phases at low temperature and 
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multi-phases (cubic/hexagonal/lamellar) at high temperature
101
. Gelation temperatures of 
MBCPs at which the polymer solution underwent sol-gel phase transition were different from 
those of their corresponding Pluronic
®
. Moreover, the CGC of MBCPs determined from Figure 9 
was 10 wt%, which was lower than that of their Pluronic
® 
copolymers, 15 wt%.  The lowered 
CGC and altered gelation temperature after oligomerization is primarily due to extended and 
enforced chain entanglements in MBCPs compared to their corresponding Pluronic
®
 
copolymers
9,102
. Based on the test tube inverting method, a polymer concentration of 25 wt% was 
chosen for the measurements of dynamic viscosity using falling ball method. Figure 10 shows 
the dynamic viscosity changes of MBCP-1 and MBCP-2 polymer solutions with temperature. 
Dynamic viscosity dramatically increased at 25 and 22 
o
C for MBCP-1 and MBCP-2 
respectively. In addition, the sol-gel transition temperatures determined by falling ball method 
were 25.02 and 22.36 
o
C for MBCP-1 and MBCP-2 at 25 wt%. The transition temperatures 
determined by falling ball method were consistent with those values determined by test tube 
inverting method. A mere variation of 2 to 4 degrees was often observed between both the 
methods. The difference may be due to a longer time for equilibration for the falling ball method 
compared to the test tube inverting method. Even though the falling ball method would allow for 
more accurate and reliable transition temperature, the test tube inverting method would give 
better simulation of practical injection of a formulation with consideration of kinetic aspect of 
the process. Figure 11 shows the micellar size change with temperature. Determined sizes of 
micelles or micellar aggregates ranged 16-30 nm and 11-35 nm in diameter for MBCP-1 and 
MBCP-2, respectively, at temperatures below 30 
o
C. The micelle sizes were slightly increased as 
the temperature increased from 10 to 30 
o
C. However, the micelle aggregation upon a 
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temperature increase from 30 to 40 
o
C resulted in a dramatic increase in micellar sizes to the 
range of 500-700 nm. 
 
 
 
 
 
 
 
 
Figure 10: Determination of dynamic viscosity changes of MBCP-1 and MBCP-2 aqueous 
solutions as a function of temperature using falling ball method. The polymer concentration was 
25 wt%. The MBCP solutions were equilibrated for 20 minutes at each temperature. 
This indicates that the micellar aggregation is the main mechanism for sol-gel transition of 
MBCP at 30-40 
o
C. GPC chromatograms in Figure 12 show the degradation of MBCP-2 at 
different pHs. Since the degradation pattern of both MBCP-1 and MBCP-2 was similar, only the 
degradation of MBCP-2 is shown here. The polymer degraded more rapidly in acidic media than 
in neutral medium. The polymers were not degraded at pH 7.4 for even 40 days (GPC 
chromatograph for day-40 was not shown here) data for while the complete degradation was 
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observed within 4 and 18 days at pH 5.0 and 6.5, respectively. At pH 6.5, the polymer started 
degrading from day 5, which coincided with the initiation time of gel erosion. 
 
 
 
 
 
 
 
 
Figure 11: Determination of micellar size changes of MBCP-1 and MBCP-2 using dynamic light 
scattering. The micellar size changes were measured as a function of temperature. The polymer 
concentration was 4% w/v. The results represent the mean  SD for n=3. 
From these results, it is evident that the multiblock copolymers were degraded into lower 
molecular weight polymers. The degradation of hydrogel is generally affected by several factors 
such as the number of degradable bonds in the polymer
103,104
, the presence of cross-links
105
 and 
characteristics of degradable bonds
84,85
. The important factors for the degradation of the MBCP 
polymers are presumably the number of acid-labile acetal bonds and sensitivity of acetal bond to 
pH. Compared with previously reported PEG-grafted polyacetal-based polymers, MBCP 
polymers were degraded faster than the graft polymer-based polymers in an acidic medium. In 
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the case of PEG-grafted polyacetal gel, it takes about 40 days for polymer degradation at pH 
5.0
84
. The main reason for the faster degradation may be the fewer acetal bonds in MBCPs than 
in the graft polymer. 
 
Figure 12: Gel permeation chromatograms showing MBCP-2 polymer degradation at three 
different pH. The different phosphate buffers used were pH 5.0, 6.5 and 7.4. The MBCP 
polymers were degraded into lower molecular weight monomers. 
Because MBCPs have only 4 or 5 average acetal bonds in each polymer chain, the cleavage of 
small number of acetal bonds can result in Pluronic
®
 unimers or low-molecular weight oligomers 
of which solutions have a greater CGC and/or higher gelation temperature than MBCPs. 
pH 7.4 
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However, PEG-grafted polyacetal should be significantly degraded before losing 
thermosensitivity. Cleavage of small number of acetal bonds in polyacetal backbones would not 
considerably change the overall ratio of hydrophilicity to hydrophobicity in the PEG-grafted 
polyacetal. The possible degradation products of MBCPs would be initial triblock copolymer 
(PEG-PPG-PEG), and a little amount of diethylene glycol and acetaldehyde based on the 
inference from an acid-labile PEG polymer with acetal bonds
85
. Monomeric Pluronic
®
 molecular 
weights are smaller than 60,000 which is the maximum molecular weight cleared by kidneys.  
2.5. Conclusions 
Novel biodegradable thermogelling polymers with pH-sensitive acetal linkages have been 
synthesized from Pluronic
® 
copolymers by a simple method. The synthesized polymers did not 
cause significant cytotoxicity. The aqueous solutions of these polymers underwent gelation at 
body temperature and the gelation temperature of the polymer solution was dependent on 
polymer concentration and the type of Pluronic
® 
copolymer used for the MBCP synthesis. 
Micellar aggregation was observed for both MBCP polymers at body temperature. MBCP 
polymers were degraded in a pH dependent fashion. At a neutral pH, polymers were stable for a 
long period of time while rapid degradation was observed at acidic pHs. 
“Reprinted from Acta Biomaterialia, 6, Garripelli VK, Kim JK, Namgung R, Kim WJ, Repka 
MA, Jo S, A novel thermosensitive polymer with pH-dependent degradation for drug delivery, 
477-485, Copyright (2010), with permission from Elsevier Limited.” 
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CHAPTER-3 
DRUG RELEASE FROM pH-SENSITIVE MULTIBLOCK COPOLYMER 
THERMOGEL 
3.1. Abstract 
MBCP-2 thermogel has been proposed for sustained release of therapeutic agents. Hydrophobic 
small-molecule drugs (paclitaxel (PTX) and camptothecin (CPT)) and model hydrophilic 
macromolecules (FITC-dextrans of molecular weights 10, 20, 40, 150 and 250 kDa) were 
successfully loaded into and released from the thermogels. Drug loaded polymer solutions were 
characterized for gelation behavior and micelle size. Drug loading increased the size of the 
multiblock copolymer micelles from 20 to 100 nm. The copolymer improved PTX and CPT 
loading in an aqueous solution by 6900 and 1050 fold, respectively, comparing to their solubility 
in water. The thermogels released loaded drugs in a pH-dependent fashion regardless of their 
properties. At pH 5.0 and 6.5, PTX and CPT completely released in 4 and 15 days, respectively, 
by a combined mechanism of diffusion and erosion. At neutral pH, diffusion predominated gel 
erosion to sustain the drug release up to 40 days. FITC-dextran release from the thermogels 
showed a similar pH-dependent trend as the hydrophobic small molecule drugs. However, 
dextran release at neutral pH was entirely dependent on the molecular weight of dextrans. Low 
molecular weight (10 and 20 kDa) dextrans  were completely released in 12 and 21 days, 
respectively, while high molecular weight (  40 kDa) dextrans being continuously released over 
36 days indicating that the threshold of molecular weight necessary for sustained release of a 
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hydrophilic macromolecule from this thermogel (eg: enzymes, monoclonal antibodies, 
immunotoxins etc.) is 40 kDa. Taken all together, MBCP-2 thermogel showed potential as a 
controlled drug delivery system that sustains the release of both hydrophilic and lipophilic 
molecules. 
3.2. Introduction 
For the last few years, research has been directed towards developing thermogel systems which 
can deliver a variety of therapeutic chemicals at a predetermined rate
12,106-110
. Recently, two 
model drugs, vitamin B12 (VB12) and bovine serum albumin (BSA), were studied with PEG-
PCL-PEG triblock copolymer thermogel, which resulted in a sustained drug release (4-12 days) 
with severe initial burst release at the first day
107
. Diffusion was the main mechanism for the 
release of both drugs. Especially, hydrophilic VB12 was rapidly released from the thermogel 
comparing to the BSA. Honokiol and BSA have been investigated for their release from PCL-
PEG-PCL thermogels
108
. Despite the hypothesis that thermogels can be applied for sustained 
delivery of various chemicals with different physicochemical properties, they were able to 
demonstrate sustained drug release only for less than 2 weeks even at polymer concentrations 
high as 20, 30 wt%. Another thermosensitive hydrogel based on poly(organophosphazene) 
released the incorporated FITC-dextran (Mw 71,600 Da) and human serum albumin (HAS) for 
over two weeks and the drug release was entirely dependent on the polymer concentration
109
. 
However, from the previous findings, it should be noted that thermogelling system shows 
limitation in sustained release of hydrophilic chemicals. Two different model macromolecules, 
lysozyme and bromelain, were studied with polyethylene oxide/polylactic acid based copolymer 
and their release from the thermogel lasted for 2-8 days
110
. It is reported that the bromelain was 
released at a slower rate comparing to lysozyme because of its relatively hydrophobic nature 
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comparing to lysozyme. The slower bromelain release than lysozyme also supported the idea that   
thermogels work better with hydrophobic chemicals than hydrophilic chemicals. It is worth 
mentioning OncoGel™, a thermogel formulation of PTX in ReGel® which is currently under 
phase II clinical trials
106
. ReGel
®
 has extended the in vitro release of insulin and porcine growth 
hormone for up to 7 and 14 days, respectively, while sustaining hydrophobic PTX release over 
50 days
12
. 
Although various thermogel systems have been proposed for sustained release of therapeutics, 
thus far, only limited knowledge is available for understanding the relationship between the 
molecular properties associated with drugs and their release from thermogels. With the current 
research work, we studied the factors associated with drugs to release nonelectrolyte model 
chemicals with different molecular and physicochemical properties using MBCP-2
2,111,112
. 
MBCP-2 has been synthesized from a triblock copolymer, PEG-PPG-PEG, Pluronic
®
 P104, 
which has weak gelation and dissolution properties. However, MBCP-2 formed after 
oligomerization of Pluronic
®
 P104, showed dual-sensitivity to temperature and pH with 
improved gelation, dissolution and drug release properties comparing to Pluronic
®
 P104 
thermogel. 
Taken all together, the main goal of this research work is to evaluate the effects of pH of the 
release media, hydrophilicity, hydrophobicity and molecular weight of the chemicals on their 
release from MBCP-2 thermogel. Hydrophilic macromolecules (FITC-dextran) of different 
molecular weights and hydrophobic PTX and CPT were studied as nonelectrolyte models 
chemicals. 
3.3. Experimental 
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3.3.1. Materials 
Pluronic
®
 P104 was received from BASF chemical company (Florham Park, NJ) as a gift. PTX 
and CPT were purchased from LC Laboratories (Woburn, MA) and Fisher Scientific (Pittsburgh, 
PA) respectively. FITC-dextran (10, 20, 40, 150 and 250 kDa) was received from Sigma (Saint 
Louis, MO). All other chemicals were obtained from Fisher Scientific (Pittsburgh, PA) and used 
without further purification. 
3.3.2. Synthesis of MBCP-2 
Synthesis of MBCP-2 was described in Section 2.3.2. 
3.3.3. DSC of polymer solutions 
Polymer solutions (Pluronic
®
 P104 and MBCP-2) were prepared in deionized water in the 
concentration range 1 to 25 wt%. Samples were gently stirred at 4 °C for 12 h. Aluminum cells 
were loaded with accurately weighed polymer solution (~5 mg) and reference cells were made 
up with same amount of deionized water.  Thermographs of the polymer solutions were recorded 
on Diamond DSC (Perkin Elmer, Waltham, MA) in a temperature range of -10 to 50 °C at 5 
°C/min. Before recording the thermographs, samples were thermally equilibrated at -10 °C for 15 
min. Dry nitrogen at a rate of 20 mL/min was continuously supplied throughout the 
measurement. 
3.3.4. Thermal gelation 
A solvent evaporation method was used to load PTX and CPT at 1 mg/ml in MBCP-2 solutions. 
Required amount of MBCP-2 was dissolved in 200 µL of the acetone. After partial removal of 
acetone by dry nitrogen flushing, 20 µL of the acetone containing 1000 µg of PTX or CPT was 
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added to the polymer solution. By continuously mixing the polymer-drug mixture, acetone was 
removed by dry nitrogen flushing. The mixture was vacuum dried for 12 hr to remove traces of 
acetone. Later, MBCP-2-drug mixtures were dissolved in deionized water at 4 °C to achieve 10, 
15, 20 and 25 wt% MBCP-2 solutions. FITC-dextran (10 mg/ml) was dissolved in MBCP-2 
solutions (10, 15, 20 and 25 wt%) by simple mixing. Phase transition temperatures of MBCP-2 
solutions in presence or absence of drug loading was measured using a test tube inverting 
method
56,113
. One milliliter of MBCP-2 and MBCP-2-drug solutions were loaded into 4 mL vials 
and equilibrated at 10 °C for 15 min. The sol-gel and gel-sol transitions of the polymer solutions 
were tested by test tube inversions in the range of 10-80 °C and at a rate of 1 °C/5 min. Vials 
were inverted and the solutions were tested based on flow or non-flow criteria for every five 
minutes. Temperature at which the polymer solution stopped flowing upon the tube inversion 
was considered as the gelation temperature of the particular concentration. 
3.3.5. DLS 
PTX and CPT were loaded in MBCP-2 solutions (0.5, 0.7, 0.9, 1.0, 2.0 and 4.0 wt%) at a 
concentration of 300 µg/mL by the solvent evaporation method described in previous section. 
Drug free MBCP-2 micelles were also prepared at the same concentrations. The polymer 
solutions were mixed at 4 °C for 24 h. Later, the solutions were filtered through 0.45 µ syringe 
filter to remove undissolved particles. Finally, the size of the empty and drug loaded micelles 
was measured using Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) at 25 °C. 
3.3.6. Transmission electron microscopy (TEM) 
MBCP-2 micelles (1 wt%) were loaded with PTX or CPT at a concentration of 300 µg/mL by 
the solvent evaporation method.  The polymer solutions were kept at 4 °C for overnight to 
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disperse the micelles in water. Later, the solutions were filtered through 0.45 µ syringe filter to 
remove any undissolved particles. The filtered solutions were transferred onto hydrophilic-
treated grids, which were then rinsed with deionized water. Excess water was removed with filter 
paper and the grids were left overnight in vacuum oven for complete dryness. Finally, the 
samples were imaged by TEM (Hitachi-7600) operated at an acceleration voltage of 80 kV. 
3.3.7. Release of hydrophobic drugs 
PTX and CPT were incorporated in MBCP-2 gels (25 wt%) at 1.00 mg/mL and 0.75 mg/mL 
respectively, by the solvent evaporation method. One milliliter of drug loaded MBCP-2 solution 
was placed in each 15 mL amber colored vial and allowed for gelation by incubation at 37 °C for 
15 min. Eight milliliters of phosphate buffer (pH 5.0, 6.5 and 7.4; 50 mM; 1 wt% Tween 80) 
were added on top of the gels in each vial. While incubating at 37 °C, release media were 
completely replaced with fresh media at different time intervals to maintain perfect sink 
conditions for both drugs
113
. Concentration of the released PTX and CPT was determined by 
high performance liquid chromatography (HPLC). HPLC was run on a Waters system (Waters, 
Milford, MA) equipped with a binary pump, a dual absorbance detector, and a Symmetry
®
 C18 
column (150 × 4.6 mm I.D.; 5 µm particle size). For the detection of PTX, mobile phase 
composed of methanol and water at a ratio of 70:30 was eluted at a flow rate of 0.8 mL/min at 25
 
o
C. The dual absorbance detector was set to 230 nm. In case of CPT detection, methanol and 
water at a ratio of 55:45 was eluted at a flow rate of 1.0 mL/min at 25 
o
C. Wavelength for the 
detection of CPT was 254 nm. Also, the retention times of PTX and CPT were 7.2 and 6.8 min 
respectively.  Calibration curves for PTX and CPT (Figure 13) at pH 5.0, 6.5 and 7.4 were  
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Figure 13: Calibration curves for PTX at pH 5.0 (A), 6.5 (C) and 7.4 (E); CPT at pH 5.0 (B), 6.5 
(D) and 7.4 (F). 
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Figure 14: Calibration curves for FITC-Dextrans with various molecular weights such as 10 
kDa (A), 20 kDa (B), 40 kDa (C), 150 kDa (D) and 250 kDa (E) in pH 5.0.  
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Figure 15: Calibration curves for FITC-Dextrans with various molecular weights such as 10 
kDa (A), 20 kDa (B), 40 kDa (C), 150 kDa (D) and 250 kDa (E) in pH 6.5. 
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Figure 16: Calibration curves for FITC-Dextrans with various molecular weights such as 10 
kDa (A), 20 kDa (B), 40 kDa (C), 150 kDa (D) and 250 kDa (E) in pH 7.4. 
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plotted using peak area of the drug versus drug concentration. Such calibration curves were used 
to calculate drug concentration in the samples.  
3.3.8. Release of hydrophilic model drugs 
FITC-dextran (10, 20, 40, 150 and 250 kDa) at a concentration of 10 mg/ml was dissolved in 25 
wt% MBCP-2 solution with stirring at 4 °C. The polymer solutions (1 mL) were loaded in amber 
color vials and allowed for gelation at 37 °C for 15 min. Two milliliters of citric buffer (pH 5.0; 
50 mM) or phosphate buffer (pH 6.5 and 7.4; 50 mM) were added on top of the gels. While 
incubating at 37 °C with periodic medium changes, samples were collected at different time 
intervals. Samples were analyzed using UV-visible spectrophotometer at 455 nm. Calibration 
curves for FITC-dextran at pH 5.0, 6.5 and 7.4 (Figure 14, 15 and 16) were plotted using the 
absorbance at 455 nm versus drug concentration. Such calibration curves were used to calculate 
FITC-dextran concentration in the release samples. 
3.3.9. Data analysis and statistics 
Student‟s t-test was used to perform the statistical comparison. A probability value less than 0.05 
was considered significant. An add-in program, DDSolver, was used to compute the similarity 
factors for the drug release from thermogels
114
. Release profiles with similarity factor greater 
than 50 were considered similar
115
. 
3.4. Results and Discussion 
MBCP-2 solutions presented sol-gel-sol transition upon a temperature increase and gelation 
temperature was dependent on polymer concentration. In addition, oligomerization of Pluronic
®
 
P104 resulted in MBCP-2 with clinically acceptable gelation properties. A broad gelation 
51 
 
window comparing to Pluronic
®
 P104 was observed for MBCP-2.  Being amphiphilic in nature, 
MBCP-2 self assembled to generate polymeric micelles and, therefore, micellization process has 
been studied calorimetrically. Micellization is an endothermic process which can be 
characterized by a transition in a DSC thermograph
116
. Onset temperature at which micelles start 
to form is considered as CMT at the particular concentration. CMT values of Pluronic
®
 P104 and 
MBCP-2 solutions are provided in Figure 17.  
 
 
 
 
 
 
 
 
 
Figure 17: Determination of CMT values of Pluronic
® 
P104 and MBCP-2 solutions by DSC. The 
CMT values represent the mean ±SD of three experiments.  
With increase in polymer concentration, CMT values decreased gradually for Pluronic
®
 P104 
and MBCP-2. These changes are in complete accordance with previously reported trend for 
Pluronic
®
 P104
97,117
. It is evident from the data that the CMT values of MBCP-2 were slightly 
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lower than Pluronic
®
 P104, which is mainly due to the increased molecular weight of MBCP-2 
comparing to Pluronic
®
 P104, as high molecular weight Pluronic
®
 copolymers are known to 
favor easy self assembly comparing to the low molecular weight polymers with the similar 
hydrophobic to hydrophilic ratio
97
. 
 
 
 
 
 
 
 
 
 
Figure 18: Sol-gel-sol transition phase diagram of MBCP-2 solutions in presence of PTX (1000 
µg/mL). The results represent the mean ±SD for n=3. 
Additives are known to exert special effects on the gelation process of the thermosensitive 
polymers. Gelation temperature of a thermosensitive polymer solution can be tuned by the 
addition of different agents such as NaCl, NaSCN and glucose
11,107
. Therefore, it is imperative to 
study the effect of loaded drugs such as PTX, CPT and FITC-dextran on the gelation process of 
53 
 
MBCP-2. At the concentrations employed for in vitro drug release study, none of the loaded 
drugs showed a noticeable effect on the sol-gel-sol transition of MBCP-2 solutions. This may be 
due to the fact that the drug concentrations used for gelation study are not high enough to 
produce such an effect. However, in Figure 18, a slight shift in the MBCP-2 gelation curve is 
observed upon the addition of PTX which is believed to be an effect induced by alterations of 
inter-micellar interactions 
118
.  
Table 2: Determination of micelle size of MBCP-2 in presence or absence of PTX and CPT using 
DLS. The results represent the mean ±SD for n=3. 
 
As micelle formation plays a key role in the gelation process of MBCP-2
111
, micelle size was 
measured in presence of loaded drugs using DLS. Table 2 shows the variation in MBCP-2 
micelle sizes in presence or absence of PTX and CPT. Mean diameter of plain micelles was 
between 20-40 nm, while the sizes of drug loaded micelles were 40-100 nm indicating that drug 
loading prominently increased micelle size. To support DLS data, the micelles were also 
visualized by TEM and the observed sizes of the micelles in Figure 19 were ~40, ~70 and ~100 
MBCP-2 
concentration 
(wt%) 
Micelle size (nm) 
MBCP-2 micelles 
PTX loaded MBCP-2  
micelles 
CPT loaded 
MBCP-2 micelles 
0.5 25.3 (±7.0) 36.7 (±6.7) 69.4 (±4.2) 
0.7 27.0 (±3.6) 71.3 (±5.1) 81.1 (±4.7) 
0.9 25.0 (±13.2) 69.4 (±11.1) 80.1 (±4.7) 
1 37.7 (±10.0) 69.7 (±3.5) 94.8 (±13.8) 
2 35.0 (±5.7) 87.7 (±3.5) 99.9 (±5.5) 
4 30.7 (±4.9) 85.0 (±12.3) 90.3 (±4.9) 
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nm for MBCP-2, PTX loaded MBCP-2 and CPT loaded MBCP-2 respectively, at a MBCP-2 
concentration of 1 wt%. Micelle sizes observed in TEM images were similar to the values 
obtained from DLS indicating that there is a good correlation between TEM and DLS data for 
MBCP-2.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: TEM images of micelles of A) Pluronic® P104, B) MBCP-2, C) PTX-loaded MBCP-
2 and D) CPT-loaded MBCP-2 at 1 wt% polymer concentration. 
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Apart from drug loaded micelles, an important observation was made for drug free micelles of 
Pluronic
®
 P104 and MBCP-2. The sizes of Pluronic
®
 P104 and MBCP-2 micelles were found to 
be 16.6 (±0.3) and 37.7 (±10.1) nm respectively, at 1 wt% using DLS. A significant (P=0.03) 
increase in the micelle size of MBCP-2 comparing to Pluronic
®
 P104 was observed, which is 
also confirmed by TEM images. This is mainly due to the increase in the molecular weight of 
MBCP-2 (Mw: 40210 Da) upon the oligomerization of Pluronic
®
 P104 (Mw: 9880 Da)
111
. 
 
 
 
 
 
 
 
 
 
Figure 20: PTX and CPT loading in water in presence of MBCP-2. The aqueous solubilities of 
PTX and CPT are 0.3 and 1.3 µg/mL respectively. The loading efficiencies of both drugs 
increased linearly with increase in MBCP-2 concentration. The results represent the mean ±SD 
for n=3. 
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Based on the phase transition and the dynamic viscosity measurements
111
, an optimum polymer 
concentration (25 wt%) was selected for drug release study. Under refrigerated conditions, the 
polymer solution (25 wt%) was a freely flowable liquid which can pass through a 22-guage 
needle warranting facile administration into the body. Also, the polymer solution quickly (<1 
min) turned to gel upon a temperature increase to 37 °C. Injectability at low temperature and 
rapid gelation at body temperature demonstrates the clinical applicability of MBCP-2 as a local 
drug delivery system. 
In vitro drug release from the thermogel was studied for lipophilic and hydrophilic drugs. In case 
of lipophilic drugs, two anti-cancer chemicals such as PTX and CPT were chosen to study the 
release at pH 5.0, 6.5 and 7.4. PTX and CPT are strong anti-tumor drugs but the therapeutic 
efficacy of both drugs has been limited by low solubility in water and potential systemic side-
effects
119,120
. Current MBCP-2 thermogel system would overcome such problems by local 
administration of drugs directly into tumor. As MBCP-2 was already shown to form micelles in 
water, PTX and CPT loading efficiencies in MBCP-2 solution were expected to increase. Figure 
20 shows the improvement in loading of PTX and CPT in water in presence of MBCP-2. 
Aqueous loading of both drugs increased with increase in polymer concentration. At 25 wt% 
MBCP-2, PTX and CPT were loaded at 2070.90 and 1374.90 µg/mL respectively, in water. 
Nearly 6900 and 1050 fold increases comparing to the aqueous solubility of PTX (0.30 
µg/mL)
8,113
 and CPT (1.30 µg/mL)
121
 respectively, were achieved. A concentration (1.00 mg/mL 
for PTX and 0.75 mg/mL for CPT) below the solubility of PTX and CPT at 25 wt% MBCP-2 
was chosen for in vitro drug release study. Release profiles in Figure 21 indicate that the drug 
release is greatly dependent on the pH of the medium. Both drugs released from the thermogels 
in nearly 4, 15 and 40 days at pH 5.0, 6.5 and 7.4 respectively. 
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Figure 21. In vitro release of (a) PTX and (b) CPT from MBCP-2 thermogels at pH 5.0, 6.5 and 
7.4. PTX and CPT were loaded at 1 mg/mL and 0.75 mg/mL respectively, in 25 wt% MBCP-2 
thermogel. The results represent the mean ±SD for n=3. 
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In vitro release profiles were in accordance with MBCP-2 degradation reported previously
111
. 
MBCP-2 degraded in 4 and 18 days at pH 5.0 and 6.5 respectively, where as it showed minimum 
or no degradation at pH 7.4 for 40 days.  In an acidic pH 5.0, polymer degraded and released the 
loaded drug rapidly. It is evident that the release at pH 5.0 is predominantly erosion controlled 
while the release at pH 6.5 is both diffusion and erosion controlled. Most importantly, diffusion 
was the main mechanism responsible for drug release at neutral conditions. Also, to better 
understand the release profiles, the data were fitted to the Ritger-Peppas equation
122-124
: 
M
t
/M
∞
=kt
n
             (1)  
where M
t
/M
∞
 is fractional release of the loaded drug at time t, k is a kinetic constant and n is a 
release exponent that indicates drug release mechanism. An n value less than 0.5 suggests 
Fickian diffusion while an n value greater than 1.0 indicates surface erosion based release. In 
addition, an n value between 0.5 and 1.0 indicates a release based on both mechanisms.  
Table 3: Release kinetics of PTX and CPT from MBCP-2 thermogels at pH 5.0, 6.5 and 7.4. 
Kinetic parameters were calculated using Ritger-Peppas model. 
Drug 
 pH of the release 
medium 
 
Ritger-Peppas model 
  
n k (h
-n
) r
2
 
PTX 
 
5.0 
 
1.126 0.008 0.973 
  
6.5 
 
0.762 0.008 0.953 
  
7.4 
 
0.498 0.014 0.916 
CPT 
 
5.0 
 
1.416 0.005 0.941 
  
6.5 
 
0.730 0.012 0.954 
  
7.4 
 
0.493 0.019 0.934 
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Table 3 shows the kinetic parameters (n, k and r
2
) for PTX and CPT release at pH 5.0, 6.5 and 
7.4. As showed in the table 3, n values for release profiles at pH 5.0 were greater than 1.0, 
indicating surface erosion based release. In addition, profiles at pH 6.5 showed a release based 
on both diffusion and erosion (n: ~0.7).  Finally, the n values for release profiles at pH 7.4 were 
less than 0.5, confirming diffusion based release. A unit drop in the pH of the media showed a 
marked increase in polymer degradation and drug release and a similar effect is expected even in 
a biological setting. A slight change in biological pH caused by a disease should be adequate to 
trigger drug release from thermogel. The findings imply that the pH of the release medium 
played an important role in the drug release, which can be translated into polymeric drug 
delivery systems that locally administer drugs in response to biological pH changes. Especially 
in cancer conditions, a significant drop in the pH of the extracellular tumor fluid is often 
observed. Depending on the type and intensity of the tumor, extracellular pH can go down to 
6.5
86,88
. In such conditions, the thermogel is expected to respond to pH variations and self 
regulate the drug release depending on the disease intensity. 
To investigate drug release behavior for hydrophilic drugs, FITC- dextrans of different molecular 
weights (10, 20, 40, 150 and 250 kDa) were loaded into MBCP-2 thermogels. Fluorescent 
labeled dextrans are commercially available in different molecular weights and they provided a 
good model for studying a size based drug release from MBCP-2 thermogel. Release profiles of 
FITC-dextran at pH 5.0, 6.5 and 7.4 are shown in Figure 22. FITC-dextran release was 
completed within 2 and 9 days at pH 5.0 and 6.5, respectively. As expected, at low pH, dextran 
release was relatively swift comparing to pH 7.4. However, it is quite interesting to note the data 
at pH 7.4, as different dextrans released from the thermogel differently. The release at pH 7.4 
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clearly answers the question: what is the optimum molecular weight of the hydrophilic drug that 
can be  
 
Figure 22: In vitro release of FITC-dextran (10, 20, 40, 150 and 250 kDa) from MBCP-2 
thermogels at (a) pH 5.0, (b) pH 6.5 and (c) pH 7.4. FITC-dextran was loaded at 10 mg/mL in 25 
wt% MBCP-2 thermogel. The results represent the mean ±SD for n=5. 
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released from MBCP-2 thermogel in a sustained manner? At the neutral pH, dextrans of 
molecular weight 10 and 20 kDa were completely released in 12 and 21 days respectively. 
However, dextrans of molecular weight greater than 40 kDa were released for 36 days. Also, to 
confirm the similarity between the release profiles, similarity factor (f2) of the release profiles 
were computed comparing to the release profile of 40 kDa dextran and the values are provided in 
table 4. It is generally accepted that release profiles with f2 values between 50 and 100 are 
considered similar
115
. The f2 values of release profiles of 150 kDa and 250 kDa were greater than 
50 whereas the f2 values of release profiles of 10 kDa and 20 kDa were less than 50 when 
compared with the release profile of 40 kDa. This clearly implies that the release of 40, 150 and 
250 kDa are similar among all the released FITC-dextrans. For a better understand of the release 
profile at pH 7.4, the data were fitted to the Ritger-Peppas equation (equation 1). Table 4 shows 
the kinetic parameters (n, k and r
2
) for FITC-dextran release at pH 7.4.  
Table 4: Release kinetics of FITC-dextrans from MBCP-2 thermogels at pH 7.4. Similarity 
factors were calculated for all the release profiles comparing to the release profile of 40 kDa. 
 
 
 
 
 
 
 
Molecular 
weight of 
FITC-dextran 
 
Ritger-Peppas model 
 
Fick's second 
law  Similarity 
factor (f2) 
 
n k (h
-n
) r
2
 
 
D (µm
2
/s) 
 
10 kDa 
 
0.541 0.062 0.984 
 
499.061 
 
15.3 
20 kDa 
 
0.575 0.035 0.969 
 
303.552 
 
23.7 
40 kDa 
 
0.591 0.014 0.982 
 
134.979 
 
- 
150 kDa 
 
0.604 0.011 0.987 
 
121.437 
 
70.3 
250 kDa 
 
0.612 0.009 0.978 
 
119.710 
 
57.1 
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From the data it is evident that the n values are between 0.5-0.6 showing that both diffusion and 
erosion were responsible for drug release. However, it can be assumed that diffusion has more 
influence on drug release comparing to surface erosion, since n values are close to 0.5. In 
addition, n values increased with increase in molecular weight of the dextran, meaning that small 
molecular weight dextrans are more affected by diffusion comparing to large dextrans. A closer 
analysis of the k values indicates that there was a gradual drop in the release rates on increase in 
the size of the loaded dextran, which implies that the movement and release of the dextran 
molecules are restricted by their size and the mesh size of the hydrogel
122
. Also, to gain an 
insight into the diffusion coefficients of FITC-dextrans, release data were fitted to early-time 
approximation equation of Fick‟s second law123. Fick‟s second law equation:  
M
t
/M
∞
=4(Dt/δ2)1/2                        (2) 
where M
t
/M
∞
 is fractional release of dextran at time t, D is a diffusion coefficient and δ is 
diffusional distance (thickness of the gel: 6000 µm). D values are provided in table 3 and not 
surprisingly, the diffusion coefficients decreased with increase in dextran molecular weight, 
which is in complete accordance with the data published by Censi et al.
122
. According to their 
findings, the size of the loaded protein molecule has a significant role in controlling the drug 
release from thermogel. MBCP-2 thermogel was able to sustain the release of high molecular 
weight dextrans whereas in case of small molecular weight dextrans, thermogel was not able to 
retain the loaded drugs long enough to sustain their release.  
Taken all together, dextran release essentially draws a conclusion that the minimum molecular 
weight necessary for a hydrophilic drug to sustain its release from MBCP-2 thermogel is 40 kDa. 
MBCP-2 is a suitable candidate for controlled delivery of therapeutic proteins such as 
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monoclonal antibodies, immunotoxins and enzymes with molecular weight equal to or greater 
than 40 kDa. The thermogel system would not be limited to the delivery of therapeutic proteins, 
but would also have applications for small molecule drugs for a sustained drug therapy. Also, the 
knowledge obtained from the current findings can be useful in the development of novel 
biomaterials intended for drug delivery applications. 
3.5. Conclusions 
A pH sensitive multiblock copolymer thermogel has been developed for local delivery of 
hydrophilic and hydrophobic drugs. Micellization of MBCP-2 was studied thermodynamically 
using DSC. Formation of MBCP-2 micelles and drug loading into the micelles was confirmed by 
DLS and TEM. Hydrophilic drugs were loaded into the thermogels by simple mixing whereas 
hydrophobic drugs utilized a solvent evaporation technique for drug incorporation. Thermogels 
released the loaded drugs in a pH-dependent fashion. Especially, release of hydrophilic drugs 
from the thermogels was dependent on the molecular weight of the loaded drug. A molecular 
weight of 40 kDa or above is necessary for a sustained release of hydrophilic macromolecules 
from MBCP-2 thermogels. The relationship between the physicochemical properties of the drugs 
and their release from thermogel has been better explained. Furthermore, the current system 
would provide a platform for the sustained delivery of small molecule drugs as well as large 
molecule proteins. 
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CHAPTER-4 
NANOCOMPOSITE THERMOGEL FOR CONTROLLED RELEASE OF SMALL 
PROTEINS 
 
4.1. Abstract 
A NCT comprised of Pluronic
®
-based multiblock copolymer (MBCP-2) and laponite (LA) 
nanoclay has been developed for sustained delivery of low molecular weight (LMW) proteins. 
Rapid release of LMW proteins from MBCP-2 thermogel has been a problem for sustained drug 
delivery. We overcome the limitation by delivering the proteins using NCT approach. Lysozyme 
(Mw: 14700 Da), a relatively LMW protein, was successfully loaded into and released from NCT. 
In addition, interactions among MBCP-2, laponite and lysozyme were studied in terms of 
gelation, micellization, particle size and zeta potential. Micellization process of the composite 
solutions was monitored using DSC. CMTs and sol-gel transition temperatures of MBCP-2 
solutions lowered on laponite addition. Positively charged lysozyme adsorbed onto anionic 
surfaces of laponite and the amount of adsorption increased with increase in lysozyme 
concentration. Particle size and zeta potential of laponite-lysozyme complex were also dependent 
on lysozyme concentration. Finally, NCT sustained lysozyme release to 40 days whereas 
lysozyme release from MBCP-2 thermogel lasted for only 18 days. The structural stability of 
released lysozyme was confirmed by CD spectroscopy and DSC. 
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4.2. Introduction 
Designing of polymer-nanoclay based composite thermogels would be a beneficial approach for 
sustained delivery of therapeutics. A synergistic improvement in the characteristics of composite 
thermogels can be attained by combination of nanoscale properties of the clays with adjustable 
physico-chemical properties of thermosensitive polymers. Thermogels enable simple 
administration of therapeutic agents via spontaneous depot formation at body temperature
56,111-
113,125-127
. Nanomaterials located inside a 3D supramolecular network of thermogels can alter and 
even sustain the delivery of loaded therapeutics
128,129
. Among variety of natural and synthetic 
nanomaterials available, smectite clays have been widely studied for drug delivery 
applications
130-133
. 
LA, a synthetic smectite nanoclay, is a layered magnesium silicate and it exists as nanoscale 
disks (25 nm diameter x 1 nm thickness). LA is composed of octahedrally arranged magnesium-
oxygen-hydroxide sheets and tetrahedrally coordinated silicon-oxygen layers
133
. Together with 
appealing structure, LA holds measurable negative surface charge, which mainly arises from 
isomorphic substitution of some magnesium cations with lithium and presence of some vacant 
positions
133
. Possessing in-built surface charge (charge density: 0.014 e/Å
2
), well-defined 
architecture and large surface area for adsorption (~ 350 m
2
/g), it has been possible to utilize LA 
in various drug delivery applications
133,134
. Also, recent studies show the compatibility of LA 
towards different cells, indicating its potential for drug delivery applications
135,136
. Another 
interesting property of LA is to intercalate small molecule drugs between inter layer spaces of 
platelets
132,133
. Intercalation has significantly improved the solubility of a hydrophobic drug, 
itraconazole, and sustained its release
132
. Similar results were reported for another small 
molecule drug, donepezil, proving LA‟s ability to load and release drugs for sustained delivery 
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applications
133
. Pawar et al. studied the binding of macromolecular protein chains to charged 
surfaces of LA
134
. Gelatin A preferentially bound to anionic surfaces of LA where as gelatin B 
bound to both surface and edges. Even though the main focus of their research was to study 
protein-LA interactions, the findings provided valuable information which could be translated 
into the development of drug delivery systems. 
Several research groups studied the interactions between LA and Pluronic
®
 copolymers
137-140
. 
Pluronic
®
, a triblock copolymer of poly(ethylene glycol)-poly(propylene glycol)-poly(ethylene 
glycol), has been successfully applied as an injectable gel for local drug delivery 
applications
13,141,142
. Pluronic
® 
solutions exhibit a thermal gelation by reversible micellar 
aggregation. It was shown that, at high polymer concentrations, addition of LA would disrupt 
thermal gelation
137
. On the other hand, Sun et al. achieved thermal gelation at low Pluronic
®
 
concentrations with sufficiently high LA concentrations
139
. In this case, the self-assembling 
properties of LA warranted the gelation of Pluronic
®
 solutions at relatively low polymer 
concentrations. In another situation, gelation was induced by light-activated assembly of LA 
particles in presence of a photoacid generator
138
. Even though, several interesting findings were 
reported on LA-Pluronic
®
 interactions, none of these composite systems were applied for drug 
delivery applications. Recently, a Pluronic
®
 F127-LA composite thermogel was shown to sustain 
the release of albumin comparing to Pluronic
®
 gel alone
140
. LA incorporation significantly 
altered albumin release from the thermogel. Even though the system presented a sustained 
release, it was only limited to several days mainly because of the instability of Pluronic
®
 gel. 
Moreover, high concentrations (3 wt%) of LA were employed to achieve such a release effect. 
Here we developed a NCT consisting of Pluronic
®
 P104-based MBCP-2
111
 and LA with an 
intention to sustain the release of LMW proteins over several weeks. Previously, MBCP-2 
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sustained the release of model proteins (FITC-dextrans) with molecular weight above 40 kDa
143
. 
We hypothesize that adsorption of LMW cationic proteins onto anionic surfaces of LA would 
sustain their release from thermogel. Lysozyme (LY) was used as a model hydrophilic drug to 
verify the hypothesis. Additionally, interactions among MBCP-2, LA and LY were also 
investigated. 
4.3. Experimental 
4.3.1. Materials 
Laponite RD was purchased from Southern Clay Products (Gonzales, TX). Pluronic
®
 P104 was a 
gift from BASF chemical company (Florham Park, NJ). Chicken egg white LY was obtained 
from Sigma (St. Louis, MO). All other chemicals were purchased from Fisher Scientific 
(Pittsburgh, PA) and used without further purification. 
4.3.2. Synthesis of MBCP-2 
MBCP-2 synthesis was described in chapter 2.3.2.  
4.3.3. Thermal gelation 
LA stock solution (1 wt%) was prepared by dispersing required amount of LA in deionized  
water (DW). The dispersion was mixed and sonicated for 12 hr and filtered through a 0.45 µ 
filter to remove dust particles. MBCP-2 was dissolved in DW at 5 °C and mixed for 24 hr at the 
same temperature. MBCP-2-LA and LA-LY solutions were prepared by mixing appropriate 
amounts of stock solutions at 5 °C. Also, MBCP-2-LA-LY composites were prepared by mixing 
MBCP-2 and LA-LY solutions. Composite solutions (1 mL) were loaded into 4 mL vials and 
equilibrated at 8 °C for 15 min. A test tube inverting method was used to measure phase 
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transition temperatures of test solution in the range of 8-50 °C
56,113
. Sample vials were heated at 
a rate of 0.2 °C/min. Vials were inverted and tested based on flow or non-flow criteria for every 
five minutes. The temperature at which the polymer solution stopped flowing upon the tube 
inversion was considered as the gelation temperature. 
4.3.4. DSC of composite solutions 
MBCP-2-LY composite solutions were prepared by the method described in previous section. 
After 12 hr incubation at 4 °C, samples were accurately weighed (~ 7 mg) and loaded into 
aluminum cells. Also, reference cells were charged with same amount of DW. Thermographs of 
composite solutions were recorded on Diamond DSC (Perkin Elmer, Waltham, MA) in a 
temperature range of -10 to 50 °C at 5 °C/min. Before recording the thermographs, samples were 
thermally equilibrated at -10 °C for 5 min. Dry nitrogen at a rate of 20 mL/min was continuously 
supplied throughout the measurement. 
4.3.5. DLS 
Interactions between LA and LY were studied using DLS. LA-LY mixtures were prepared by 
mixing LA and LY stock solutions for 1 hr. The mixtures were sonicated for 5 min, filtered 
through 0.45 µ syringe filter and measured for particle size and zeta potential using Zetasizer 
Nano ZS (Malvern Instruments, Malvern, UK) at 25 °C. 
4.3.6. LY release from the thermogels 
LA-LY complex was prepared by mixing 250 µL of LY (8 mg/mL in DW) and 500 µL of LA 
solution (2 wt%) for 30 min. To LA-LY complex solution, 250 µg of MBCP-2 was added and 
the solution was mixed for 12 hr at 4 °C. The final concentrations of MBCP-2, LA and LY in the 
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composite solution were 25 wt%, 1 wt% and 2 mg/mL respectively. The composite solution was 
charged into 4 mL vial and the loaded vials were equilibrated at 37 °C for 15 min to form NCTs. 
LA free thermogels were prepared in the similar method. Phosphate buffer (2 mL, pH 7.4, 50 
mM) was added on top of the thermogels to release LY. Release medium was fully replaced with 
fresh buffer at predetermined time intervals. The amount of released LY was determined by 
micro-BCA protein assay
144
. A calibration curve for LY (Figure 23) was plotted using the 
absorbance at 540 nm versus LY concentration. 
 
 
 
 
 
 
 
 
Figure 23: Calibration curve for LY at pH 7.4 developed using BCA protein assay. 
4.3.7. Structural stability of released LY 
CD spectroscopy and DSC were used to study the stability of LY in the release media
145,146
. CD 
spectra of native LY and LY in the release media were recorded in the wavelength range 250-
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190 nm on a CD spectrometer (Olis
®
 DSM 20 CD Spectrophotometer, Bogart, GA). LY in the 
release media was collected by freeze drying the release samples. LY was diluted with phosphate 
buffer (pH 7.4, 50 mM) to achieve concentrations in the range of 0.01-0.05 mg/mL. A cuvette 
(path length: 1 mm) was loaded with sample solution and CD spectra were recorded at room 
temperature. Sample cell compartment was purged with nitrogen at a flow rate of 15 mL/min. 
Molar ellipticity of the samples was calculated after a blank reference of phosphate buffer was 
subtracted from the raw data. DSC of lyophilized LY was run in the temperature range of 0-250 
°C at a rate of 10 °C/min. Samples were equilibrated at 0 °C for 5 min before the scanning. 
4.3.8. Data analysis and statistics 
Results are expressed as mean ±SD, where applicable. Student‟s t-test was used for statistical 
comparison. A probability value less than 0.05 was considered significant. 
4.4. Results and discussion 
Interactions between LA and Pluronic
®
 co-polymers have been extensively studied by various 
research groups
137,139,140
. Depending on concentration, temperature and type of Pluronic
®
 used, 
LA and Pluronic
®
 aqueous mixtures generate either nanocomposite hydrogels or liquid 
dispersions. Since phase transition temperature is an important criterion for practical drug 
delivery application of a thermosensitive polymer, studying the effect of LA incorporation on 
sol-gel transition of MBCP-2 was imperative. For easy administration into body, quick gelation 
at physiological temperature and a sustained drug release, MBCP-2 required to be employed 
above 20 wt%
111,143
. Therefore, effect of LA addition on gelation was studied at high polymer 
concentrations and the data is shown in Figure 24.  
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Figure 24: Sol-gel transition temperatures of MBCP-2-LA composite solutions as a function of 
LA concentration. Two MBCP-2 concentrations (20 and 25 wt%) were tested. *Significant 
difference from the sol-gel transition temperature of MBCP-2 (25 wt%) at 0 wt% LA (p < 0.05). 
**Significant difference from the sol-gel transition temperature of MBCP-2 (20 wt%) at 0 wt% 
LA (p < 0.05). The results represent the mean  SD for n=3. 
Increasing LA addition gradually lowered the gelation temperature at particular MBCP-2 
concentration. It was also observed that a minimum LA concentration was necessary to induce a 
change in the gelation temperature. For example, addition of LA at 2.5 wt% lowered the gelation 
temperature of polymer solution (25 wt%) by ~16 °C. Also, the minimum concentration of LA 
required to produce a noticeable change in gelation process was 1 wt%. This shows that gelation 
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properties of charged LA particles played an important role in the phase transition of 
nanocomposite solutions. 
 
 
 
 
 
 
 
 
 
Figure 25: Sol-gel transition temperatures of MBCP-2-LA-LY composite solutions as a function 
of LY concentration. MBCP-2 solutions (25 wt%) at 1 wt% LA were tested. 
Usually, low Pluronic
®
 concentrations are used to inhibit or slow down the gelation process of 
LA by sterically stabilizing LA particles through preferential adsorption of hydrophobic PPO 
segment onto LA surface and free dangling of PEO segment into the solution
139,147
. On the other 
hand, addition of small amounts of LA promotes the gelation of Pluronic
®
 solution, which is 
evident by recent work of Wu et al
140
. Therefore, a careful optimization of the compositions of 
MBCP-2 and LA would result in a nanocomposite with desirable viscosities at low temperatures 
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and favorable gelation properties for drug delivery at physiological temperatures. The gelation 
temperatures of MBCP-2 solutions (25 wt%) were also measured in presence of LY coated LA 
and the data is showed in Figure 25. Since the adsorption of LY on LA alters the charge on LA 
surface, it was expected that the LY adsorption would change the gelation temperatures of 
MBCP-2-LA composite solutions. Surprisingly, the sol-gel transition temperatures of MBCP-2 
solutions didn‟t change upon the addition of LY adsorbed LA.  
 
 
 
 
 
 
 
 
 
Figure 26: Determination of CMT values of MBCP-2-LA composite solutions by DSC. 
*Significant difference from CMT of MBCP-2 (25 wt%) at 0 wt% LA (p < 0.05). **Significant 
difference from CMT of MBCP-2 (20 wt%) at 0 wt% LA (p < 0.05). The values represent the 
mean ±SD of three experiments. 
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Furthermore, to better understand the gelation, the process was studied calorimetrically using 
DSC. Micellization is an endothermic process and it is often possible to study the self assembly 
of polymers in water using calorimetry
113,117
. The on-set temperature of an endothermic event in 
a thermograph is often considered as CMT at the particular polymer concentration. The CMT 
values of the composite solutions were shown in Figure 26. Since gelation of MBCP-2 solution 
was affected by the addition of LA, a similar effect on CMT of polymer solution was expected.  
All composite solutions showed broad endotherms in the temperature range of 2-20 °C. 
Importantly, CMT of MBCP-2 solutions decreased gradually on increasing LA concentration. In 
addition, effect of LA on 25 wt% polymer solution was more pronounced comparing to 20 wt% 
as shown in Figure 24. It is believed that the initiation of micellization at low temperature in 
presence of LA would be the main reason for lowering of the gelation temperature of MBCP-2 
solution. Contrary to our findings, Boucenna et al. did not see a change in CMT values of 
Pluronic
®
 F127 (16 wt%) on the addition of LA (0-3 wt%)
137
. This may be due to high molecular 
weight of MBCP-2 (Mw measured using GPC: 40210 Da) comparing to Pluronic
®
 F127 (Mw 
provided by BASF: 12500 Da) and difference in PEG/PPG value for MBCP-2 (0.67) and 
Pluronic
®
 F127 (2.33)
111,147
. According to Nelson et al., adsorption of Pluronic
®
 onto LA surface 
is highly dependent on total molecular weight of the polymer and molecular weight of PEO or 
PPO blocks
147
. 
Particle size and zeta potential of LA in presence of different concentrations of LY were shown 
in Figure 4. LY has an isoelectric point value of 10.5 with net positive charge on the protein 
surface at experimental conditions
148
. 
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Figure 27: Particle size and zeta potential of LA-LY complex as a function of LY concentration 
measured using DLS. The results represent the mean  SD for n=3. 
It has been reported that the surface of LA has good binding capacity for polyampholyte protein 
molecules
134
. Therefore, strong interactions between positively charged LY and negatively 
charged surfaces of LA are expected at neutral pH. Scheme in Figure 28 has been proposed to 
explain DLS data. According to DLS, LA has particle size of 293.8(±23.9) nm and zeta potential 
of -49.9(±4.7) mV. It has been known that LA forms dimers, trimers, oligomers, and even 
tactoids in the solution
149,150
. Therefore, the presence of large particles in LA solutions is not 
surprising because more than one LA particle can aggregate and produce large particles 
comparing to pristine LA (~40 nm)
133
 as shown in Figure 28a. At low LY concentration (0.025 
wt%), particle size (414.7(±90.1) nm) and zeta potential (-36.5(±5.3) mV) of LA-LY were 
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slightly but significantly (p<0.05) greater than LA alone indicating that LY moderately covered 
the surfaces of LA and increased the zeta potential and particle size of the complex as suggested 
in Figure 28b. Complex formation at 0.1 wt% of LY resulted in a zeta potential of ~10 mV and 
maximum particle size of 1028.9 (±47.2) nm. At this weight ratio (Figure 28c), the solution 
seemed to have enough LY to shield the charge on LA surface. Eventually, masking surface 
charges has resulted in the formation of even larger aggregates of complex in the solution. 
However, it is interesting to observe the particle size and zeta potential values of complexes at 
LY concentrations above 0.1 wt%. Particle size of the complex decreased gradually and reached 
a constant value (~150 nm) and zeta potential increased to a maximum (~30 mV) on increasing 
LY concentration. At high LY concentrations, it is believed that protein molecules were able to 
intercalate between interlayer spaces of LA and separate the aggregates into small size LA-LY 
complexes as represented in Figure 28d.  
Recent studies also suggested the possibility of increase in interlayer spaces of LA by 
intercalation of small molecule drugs such as itraconazole and donepezil
132,133
. Being a high 
molecular weight protein, LY could exert even stronger forces comparing to small molecules to 
alter the spatial arrangement of LA. In addition to particle size, zeta potential values increased 
with increasing LY concentration, which is in complete accordance with the data presented for 
montmorillonite, a nanoclay with negative surface charge similar to LA
151
. 
Furthermore, the concentration dependent adsorption was studied by measuring the amount of 
LY adsorption on LA (Figure 29). LY adsorption was only slightly increased with increase in LY 
concentration below 0.1 wt% LY. However, a drastic increase in the LY adsorption was noticed 
above 0.1 wt% LY. This could be related to increase in surface area of LA available for LY 
adsorption. As indicated in DLS data, sharp decrease in particle size above 0.1 wt% resulted in 
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increase in the surface area of LA and adsorption of LY as well. Cationic molecules adsorb onto 
negatively charged surfaces in remarkably high quantities, which is evident by recent studies on 
polycation adsorption on montmorillonite
151
. As reported, relatively high quantities of LY (upto 
3.5 mg/mL) were adsorbed onto LA surface (0.5 mg/mL). Taken all together, a good correlation 
was observed between DLS and LY adsorption data. 
 
 
 
 
 
 
 
 
 
Figure 28. Conceptual illustration showing the adsorption of LY onto LA. 
In vitro LY release from the NCT was studied at 1 wt% LA. According to previous reports, there 
exists a good correlation among LA loading in thermogel, thermogel dissolution time and drug 
release
140
. Therefore, an optimum concentration for LA (1 wt%) was chosen based on gelation 
data in Figure 24. Since the incorporation of LA at a concentration of 1 wt% was necessary for a 
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noticeable change in the gelation temperature of MBCP-2-composite, in vitro drug release study 
was performed with the composite containing relatively low concentration (1 wt%) of LA rather 
than the composite with 3 wt% of LA
140
. 
 
 
 
 
 
 
 
 
 
 
Figure 29: Adsorption of LY on LA as a function of LY concentration. LY was measured using 
BCA protein assay. The results represent the mean  SD for n=3. 
In addition, the final formulation was a free-flowing liquid which could be injected through a 25-
gauge needle presenting clinical applicability. LY release (Figure 30) from MBCP-2 thermogels 
was completed in 18 days, whereas only 45 % of the total drug was released in 18 days from 
NCT with 1 wt% LA. LY adsorption onto LA significantly slowed LA release from the 
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nanocomposite. On the other hand, free and unadsorbed LY released relatively fast from MBCP-
2 thermogel.  
 
 
 
 
 
 
 
 
Figure 30: In vitro release of LY from MBCP-2 and NCT at pH 7.4. *Significant difference from 
the cumulative percent LY release from NCT after 18 days (p < 0.05). The results represent the 
mean  SD for n=3. 
Previously, MBCP-2 thermogel sustained the release of FITC-dextran of molecular weight ≥ 40 
kDa
143
. But the current NCT was able to sustain the release of an even smaller macromolecule. 
However, it is essential that the therapeutics possess a surface charge, preferably positive charge, 
for sustaining their release. With NCT approach, sustained delivery could be achieved for a 
chemical irrespective of its molecular weight. Further, the system should not be limited to the 
delivery of macromolecules, it should also find applications for small molecules drugs. 
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Figure 31: CD spectra of native LY and LY in the release media. Molar ellipticity was plotted on 
the vertical axis. All the solutions showed two negative bands at ~ 208 nm and ~220 nm. (a) LY 
released from MBCP-2 thermogels; (b) LY released from NCT. 
It is necessary that the model protein is structurally intact even after being released from the 
NCT. Therefore, LY in the release media was investigated using CD spectroscopy to examine 
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possible effects of formulation excipients, process conditions and release medium on secondary 
structural arrangement of LY. 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: DSC thermographs of native LY and LY from the release media. (a) LY released from 
MBCP-2 thermogels; (b) LY released from NCT. DSC was run in the temperature range of 0- 
250 °C and all samples showed an endotherm in the temperature range 200-210 °C. 
Figure 31 shows the CD spectra of native LA and LA from the release samples. LY consists of 
segments with both α-helical and β-sheet arrangements. However, α-helical arrangement is 
predominantly observed with a strong negative band in the range of 200-240 nm with two 
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minima at 208 and 220 nm in the CD spectrum
152
. The spectra of native LY and the LY in 
release medium are almost identical indicating that the formulation and in-vitro release processes 
such as adsorption of LY and nanocomposite loading into thermogel were not detrimental to the 
secondary structure of LY. 
In addition to CD spectroscopy, DSC was run for released LY to determine the denaturation 
temperature (Tm) of the protein in solid state
145
. Figure 32 shows the endotherms of native LY 
and the LY in release media. LY required for DSC was collected by mixing and lyophilizing the 
triplicate samples at particular time points. The onset temperature of the endotherm was 
considered as Tm of the protein and LY showed a Tm of ~200 °C. Usually, an alteration in Tm of 
LY represents a change in its conformation
145
. As observed in Figure 32, DSC thermographs of 
LY in the release media were similar to native LY implying that the formulation conditions 
didn‟t alter LY conformation. 
Taken all together, a fine tuning of the compositions of the ingredients based on drug dose and 
duration of delivery would result in a composite system that possesses clinically appropriate 
characteristics. In addition, current NCT concept would be beneficial for an effective delivery of 
therapeutic agents to diseases that necessitate sustained therapy.  
4.5. Conclusions 
A NCT with tunable gelation properties has been successfully developed. LA incorporation 
significantly lowered gelation temperature of MBCP-2 solution. Also, the presence of LA 
lowered CMT of MBCP-2 in water. Using DLS, concentration dependent interactions between 
positively charged protein molecules and negatively charged LA were studied. Protein molecules 
successfully separated the aggregates of LA in water. Due to increase in LA surface area at high 
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LY concentration, adsorption of LY onto LA increased. LY adsorption onto LA significantly 
slowed down its release from NCT. Further, formulation conditions didn‟t alter the secondary 
structure of LY. Therefore, NCT could be suggested as a potential approach for sustained 
delivery of LMW proteins.  
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CHAPTER-5 
MATRIX METALLOPROTEINASE-SENSITIVE THERMOGELLING POLYMER FOR 
BIORESPONSIVE DRUG DELIVERY 
5.1. Abstract 
In this study, we proposed a new Pluronic
®
 based thermogelling system containing MMP2 
responsive peptide sequences. A novel thermosensitive multiblock copolymer comprising an 
MMP2-labile octapeptide (Gly-Pro-Val-Gly-Leu-Ile-Gly-Lys) was synthesized from Pluronic
®
 
triblock copolymer. The polymer was designed to form thermogel at body temperature and 
degrade in presence of MMP overexpressed in the tumor. The synthesized polymer was a 
multiblock copolymer with ~ 2.5 units of Pluronic
®
. The multiblock copolymer solutions 
exhibited a reverse thermal gelation around body temperature. The gelation temperatures of the 
multiblock copolymer solutions were lower than those of the corresponding Pluronic
®
 monomer 
at a particular concentration. The cytotoxicity of the synthesized polymer was lower comparing 
to its monomer. The solubility of hydrophobic anticancer drugs, PTX and CPT, were enhanced 
in the polymer solutions via micelle formation. The synthesized polymer was preferentially 
degraded in presence of MMP. PTX release was dependent on the enzyme concentration. These 
findings suggest that the synthesized polymer has the potential as controlled drug delivery 
system due to its unique phase transition and bioresponsive behavior. 
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5.2. Introduction 
The advance in technologies to engineer biomimetic materials has been an important 
breakthrough that would greatly influence human health care
6,75,76
. Careful fabrication of 
materials with precise consideration of the underlying cellular microenvironments made this 
approach suitable for various biomedical applications. Biomimetic materials have been 
consistently considered for drug delivery and tissue engineering
77,78,80
. These materials have 
frequently been obtained by incorporating bioactive molecules such as proteins and peptides
76,79
. 
Particularly, peptide conjugation has been proven as a vital approach to develop the biomimetic 
materials to suit the biomedical needs
12,43,81
. Several approaches have been tried to engineer 
these materials either to target the diseased tissue or to mimic the extracellular matrix
10,11,42
.  
Targeted delivery of anticancer drugs has been one of the pressing research areas using bioactive 
molecules. Anticancer therapeutic agents, such as methotrexate, PTX and cisplatin, have been 
specifically delivered to tumor tissues by conjugating them to polymers using bioactive 
molecules
13,29,46,56,153
. However, most polymeric prodrugs carrying pendent cytotoxic drugs have 
been attached to polymer backbones via a peptide linker. The critical problems associated with 
the polymeric prodrugs include low drug loading capacity and altered physicochemical 
properties of the polymeric prodrug as a whole. Another drawback associated with the polymeric 
prodrug is the release of peptide fragment-modified drug rather than intact drug molecules, 
resulting in the reduced activity of parent drug
82
. An alternative to overcome the problems 
associated with these approaches would be local drug delivery systems with enhanced drug 
loading. Particularly, the local drug delivery systems based on amphiphilic thermosensitive 
polymers has been investigated in recent years
83-85
. The thermosensitive polymer solution is a 
free-flowing fluid at room temperature allowing easy administration into the body. The polymer 
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solution turns into gel depot upon injecting into the body, where the gel depot acts a drug 
reservoir
90
. In addition, the amphiphilic polymer can improve the solubility of insoluble drugs.  
From a clinical perspective, the injectable thermogels have a great benefit because they allow 
minimally invasive drug delivery directly to the diseased tissue. 
Different thermogels were prepared with aqueous solutions of various polymeric materials such 
as chitosan, hyaluronic acid, alginate, Pluronic
®
 copolymers and poly(N-isopropylacrylamide)-
based copolymers
86-88
. Even though several different thermogelling systems have been prepared, 
the drug release from the thermogels is mainly mediated by simple diffusion and non-specific 
hydrogel erosion. These obstacles necessitate uncovering a specific mechanism to control drug 
release from the thermogels. MMPs can act as in situ controlling tools to regulate drug release 
from the thermogels. MMPs are zinc-dependent endopetidases that can cleave many of the 
extracellular matrix proteins. Many of the MMPs are found to be overexpressed and active 
during advanced stages of the cancer while they are minimally expressed in the normal tissue. 
Particularly, MMP2 and 9 (Type IV collagenases) which degrade extracellular matrices have 
been known to play a critical role in tumor progression, angiogenesis and metastasis
81
. 
Therefore, the combination of thermogelling property and enzyme sensitivity would provide a 
vital approach to engineer novel in-situ forming polymers that are suitable for bioresponsive 
local drug delivery.  
A peptide specifically degraded by MMPs is either incorporated into or conjugated to a 
thermosensitive polymer to make a thermogel system which is sensitive to MMPs. A MMP13 
sensitive peptide, QPQGLAK, has been incorporated into thermosensitive poly(N-isopropyl 
acrylamide) hydrogel matrix
10,11,96
. The peptide in the hydrogel system provided a cross-linking 
structure while maintaining thermosensitive properties. In addition, the system showed 
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concentration dependent degradation towards MMP2. Recently, an enzymatically degradable 
temperature sensitive polypeptide has been reported. The block copolymer, poly (ethylene 
glycol)-block-poly (alanine-co-phenyl alanine) (PEG-PAF), showed temperature sensitivity in 
water as well as degradability in the subcutaneous layer of rats
43
. Enzymes present in the 
subcutaneous layer such as cathepsin B, cathepsin C and elastase were assumed to be responsible 
for the degradation of polymer in vivo.  
Here we report the synthesis of novel Pluronic
®
-based multiblock copolymer connected via a 
MMP-2-sensitive peptide, Gly-Pro-Val-Gly-Leu-Ile-Gly-Lys-NH2 (GPVGLIGK-NH2). The 
hypothesis behind this project is that the combination of thermosensitive Pluronic
®
 and MMP-
sensitive peptide would result in a dual-stimuli-sensitive polymer which can form gel at body 
temperature and allow bioresponsive degradation in presence of MMP. Physical properties and 
in vitro cytotoxicity of the polymers were studied to assess in vivo applicability as a local drug 
delivery system. Finally, two chemotherapeutic agents, PTX and CPT, have been released to 
demonstrate the bioresponsive drug release from the thermogels. 
5.3. Experimental 
5.3.1. Materials 
The peptide, GPVGLIGK-NH2, was synthesized by American Peptide Company (Vista, CA). 
Pluronic
®
 P85 and P104 were kindly provided from BASF Chemical Company (Florham Park, 
NJ). Collagenase-IV was purchased from Sigma (Saint Louis, MO). PTX was obtained from LC 
Laboratories (Woburn, MA). Polystyrene standards of molecular weights 1, 4, 20, 50 and 100K 
were purchased from Polysciences, Inc. (Warrington, PA). All other chemicals were obtained 
from Fisher Scientific (Pittsburgh, PA) and used without further purification. 
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5.3.2. Polymer synthesis 
5.3.2.1. Activation of triblock copolymer  
Pluronic
®
 P85 or P104 (10 g) was dried by azeotropic distillation from 150 mL of anhydrous 
toluene. The dried Pluronic
®
 was dissolved in 20 mL of anhydrous methylene chloride. About 2 
mL of triethylamine (9.6 molar equiv.) was added to the reaction mixture at room temperature. 
After cooling the reaction mixture in an ice bath, 4-nitrophenyl chloroformate (NPC) (8.0 molar 
equiv.) was added. Initially, the mixture was allowed to react for 1 h at 0 
o
C. The reaction was 
continued overnight at room temperature under magnetic stirring. After all the solvent was 
removed, the activated Pluronic
®
 (NPC-Pluronic
®
) was dissolved in 50 mL of anhydrous ethyl 
acetate and filtered to remove precipitated triethylamine HCl. The NPC-Pluronic
®
 was 
recrystallized from 50 mL of diethyl ether to remove unreacted NPC. This step was repeated 
twice to remove most of the unreacted NPC. Finally, the NPC-Pluronic
®
 was dried under 
reduced pressure and kept in a desiccator until peptide coupling. 
5.3.2.2. Coupling of the peptide to activated triblock copolymer 
The peptide (100 mg) and NPC-Pluronic
® 
(1.1 molar amount to the peptide) were dissolved 
separately in 1 mL of dimethyl acetamide (DMA). NPC- Pluronic
®
 solution was added to the 
peptide solution at room temperature by magnetic stirring. Triethylamine (5.0 molar amount to 
the peptide) was slowly added to the reaction mixture. The reaction was carried out for one day 
(at room temperature) or two days (first day at room temperature and second day at 50 
o
C) or 
three days (one day at room temperature and two days at 50 
o
C). Dry nitrogen was flushed to 
evaporate DMA from the reaction mixture. This crude multiblock copolymer was dissolved in 
water and dialyzed (molecular weight cut off: 6000-8000, Spectra/Por
®
) against deionized water 
89 
 
for two days with periodic media changes. The final product was freeze-dried to obtain polymer 
powder. Two different multiblock copolymers, MMP-P85 from Pluronic
®
 P85 and MMP-P104 
from Pluronic
®
 P104, were synthesized with the yields of 80% and 89%, respectively. 
5.3.3. Polymer characterization 
1
H-NMR was used to analyze the chemical structures of the synthesized polymers. Polymers 
were dissolved in either CDCl3 or D2O and the spectra were recorded on a 400MHz NMR 
spectrometer (Bruker Ultrashield
TM
 400 PLUS, Germany). Waters GPC system (Waters, 
Milford, MA) equipped with a binary pump (Waters 1525), a refractive index detector (Waters 
2414) and a Styragel HR4E column (300 × 7.8 mm I.D., 5 µm particle size) was used to obtain 
the molecular weights and polydispersities of the polymers. THF was eluted at a flow rate of 1 
mL/min at 25 
o
C. Polystyrene standards (1000-50000 Da) were also run to obtain a calibration 
curve and the calibration curve was used to calculate the molecular weights of the polymers. 
Thermograms of the polymers were obtained from DSC (Perkin Elmer Diamond DSC, Waltham, 
MA). Melting temperatures of the polymers were determined from the thermograms thereafter. 
DSC was run in the temperature range of 0 to 50 
o
C with a heating and cooling rate of 10 
o
C/min. 
Initially, the samples were loaded in aluminum pans and equilibrated at 0 
o
C for 5 min. Dry 
nitrogen flow at a rate of 20 mL/min was maintained throughout the analysis. 
5.3.4. CMC of MMP-P104 
The CMCs of Pluronic
®
 P104 and MMP-P104 were determined by a dye solubilization method 
using DPH
89
.  Briefly, polymer solutions in the concentration range 1.0 × 10
-5 
to 10 wt% were 
prepared. DPH solution (10 µL, 0.4 mM in methanol) was added to 1.0 mL of each polymer 
solution. The polymer solutions were incubated at 25 
o
C for 24 h in a dark place. The absorbance 
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values of the test solutions were recorded on a Lambda EZ201 UV spectrophotometer (Perkin 
Elmer, Waltham, MA) at 377 and 391 nm. A graph was drawn plotting the difference between 
two absorbance values on vertical axis and concentration on horizontal axis. 
5.3.5. DSC of polymer solutions 
DSC thermographs of Pluronic
®
 P104 and MMP-P104 solutions were obtained in the 
concentration range of 1 to 25 wt%. Sample solutions were prepared by dissolving specific 
amount of polymer in deionized water with gentle stirring at 4 
o
C. Accurately weighed sample 
solutions (6 mg) were placed in aluminum cells and reference cells were made up with same 
amount of deionized water. DSC was run in the temperature range of -10 to 50 
o
C at a rate of 
5
o
C/min. Samples were thermally equilibrated at -10 
o
C for 15 min before the scanning.  
5.3.6. CD spectroscopy 
The CD spectra of MMP-P104 and peptide solutions were analyzed in the wavelength range of 
250 to 190 nm using a CD spectrometer (Olis
®
 DSM 20 CD Spectrophotometer, Bogart, GA). 
MMP-P104 and peptide solutions were prepared at 0.1 and 0.01 wt%, respectively. The sample 
solutions were equilibrated at 4 
o
C overnight before the analysis. A cuvette (path length-1mm) 
was charged with a sample solution and CD spectra were recorded at 15, 25, 35 and 45 
o
C. Molar 
ellipticity of all the samples was calculated after a blank reference of water was subtracted from 
the raw data.  
5.3.7. In vitro cytotoxicity 
In vitro cytotoxicity study was performed using MTT on HT1080 fibrosarcoma cells
94
. The cells 
were cultured in Roswell Park Memorial Institute medium (RPMI). The RPMI was 
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supplemented with 10% FBS and antibiotics. The cultured cells in 96-well plates (5 × 10
3
 
cells/well) were grown for 24 h at 37 
o
C. The culture medium was replaced with MMP-P104 
solution (100 µL, 0.05-1.00 wt %) in serum-free DMEM. The cells were incubated for 4 h in 
serum-free DMEM (100 µL) followed by 12 h incubation in 200 µL DMEM containing 10% 
FBS. After 16 h of total incubation, the test solutions were replaced with fresh media (200 µL) 
and 5 mg/mL MTT solution (20 µL). The cells were incubated for 4 h in MTT solution. Later, 
the MTT solution was replaced with 400 µL dimethyl sulfoxide to dissolve internalized purple 
formazan crystals. To measure the absorbance at 570 nm on a VICTOR3 V
TM
 Multilabel 
Counter (Perkin Elmer, MA, USA), 150 µL of the solution was transferred from each well into a 
fresh 96-well plate. Cell viability was calculated as compared to phosphate buffered saline 
(PBS)-treated cells (100 % survival). 
5.3.8. Thermal gelation of polymeric solutions 
5.3.8.1. Test tube inverting method 
Polymer solutions were prepared by dissolving them in deionized water at 4 
o
C. A series of 
polymer solutions at concentrations of 5, 10, 15, 20 and 25 wt% were prepared. Scintillation 
vials (4mL) were loaded with 1mL of the polymer solution and incubated at 4 
o
C overnight. The 
sol-gel and gel-sol phase transition temperatures of the each polymer solution were determined 
with increments of 2 
o
C
88,94
. The experiment was conducted in the temperature range of 15 to 80 
o
C. The temperature at which a polymer solution stopped flowing upon a tube inversion was 
recorded as gelation temperature.  
5.3.8.2. Falling ball method 
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MMP-P104 solutions at concentrations of 10, 15, 20 and 25 wt% were prepared in deinonized 
water. NMR tube of diameter 4.0 mm was filled with the polymer solution. The polymer solution 
was incubated at 10 
o
C for 20 min. A steel ball (diameter (D) =1.97 mm, density (ρs) = 7.97 
g/mL) was dropped through the polymer solution. The time (t) required for the steel ball to fall a 
specified distance (d = 3 cm) was measured with a temperature increment of 2 
o
C per step for 
each polymer concentration. The polymer solutions were equilibrated for 20 min at each 
temperature. The intersection of extrapolated lines of travel time of the steel ball on a graph 
plotted between temperature and the transit time gives the sol-gel transition temperature of the 
polymer solution
97
. The dynamic viscosity (µ) was calculated using the following formula 
µ = (γs - γf) D
2
/ (18v) 
Where, the velocity of the falling ball (v) = d/t, specific gravity of the sphere (γs) = ρsg, specific 
gravity of the polymer solution (γf) = ρfg,  and acceleration due to gravity (g) = 980 cm/s
2
. The 
density of the polymer solution (ρf) was assumed to be 1.0 g/cm
3
. 
5.3.9. MMP-P104 degradation 
The MMP-P104 solution was prepared at a concentration of 25 wt% in deinonized water. The 
polymer solution (50 µL) was placed in 1mL vials and the vials were kept at 4 
o
C overnight. The 
polymer solutions were incubated at 37 
o
C for 15 min for gelation. Phosphate buffer (0.1mL, 
50mM) was added to first three vials (control). In another three vials, phosphate buffer 
containing collagenase-IV (250µg/mL) was added. The degradation of the gels was stopped by 
freezing the gels at predetermined time intervals. The frozen samples were then freeze-dried to 
get the degraded polymer. GPC was run to check the molecular weight distribution of the 
degraded polymer. 
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Figure 33: Calibration curves for PTX and CPT developed using HPLC. 
5.3.10. In vitro PTX release 
MMP-P104 (250mg) was dissolved in 200µL of the acetone. After partial removal of acetone by 
dry nitrogen flushing, 20µL of the acetone containing 500µg of PTX was added to the polymer 
solution. By continuously mixing the polymer-drug mixture, the acetone was removed by dry 
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nitrogen flushing. Finally, the polymer-drug mixture was vacuum dried in vacuum for 4 h to 
remove the acetone completely. The MMP-P104-PTX mixture was dissolved in 750 µL water 
with vigorous stirring at 4 
o
C. The polymer-drug solution (0.2 mL) was placed in each 2 mL vial 
and allowed for gelation at 37 
o
C. The gels were equilibrated at this temperature for 15 min. 
Phosphate buffer (1.6mL, 50mM) including 1% w/v Tween 80 was added to first set of vials 
(control). Phosphate buffer (1.6mL, 50mM) composed of collagenase-IV (1, 10, 50 and 
250µg/mL), Tween 80 (1% w/v), calcium chloride (0.5mM) and sodium azide (0.2mg/mL) was 
added to another set of vials. While incubating at 37 
o
C, samples were collected and total 
medium was replaced for every 12 h to maintain perfect sink conditions. The samples were 
analyzed using HPLC. HPLC analysis conditions were described in Section 3.3.7. In addition, 
the calibration curves for PTX and CPT were shown in Figure 33. 
5.4. RESULTS & DISCUSSION 
Multiblock copolymers (MMP-P85 and MMP-P104) were synthesized by conjugating 
thermosensitive Pluronic
®
 (P85 and P104), a group of triblock copolymer of PEG-PPG-PEG, to 
a MMP-sensitive peptide (GPVGLIGK-NH2). The synthesis involves a two-step reaction as 
described in Figure 34. Initially, the hydroxyl groups at the end of the Pluronic
®
 were activated 
by NPC to yield a nitrophenyl substituted Pluronic
®
 (NPC- Pluronic
®
) at room temperature. 
Then, the NPC-Pluronic
®
 was purified by recrystallizing in diethyl ether 2-3 times. The 
Pluronic
®
 could also be activated by N-hydroxysuccinimidyl (NHS) ester. In such a case, the 
ends of the Pluronic
®
 should include carboxylic groups instead of hydroxyl groups. As this 
method includes another step of modification, NPC is preferred over NHS for the activation of 
Pluronic
®
. The 
1
H-NMR spectra of Pluronic
®
 P104 and purified NPC-Pluronic
®
 were shown in 
Figure 35. The activation of Pluronic
®
 was confirmed by the characteristic proton peaks of 4-
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nitrophenyl carbonate ranging from 7.4 to 8.4 ppm in 
1
H-NMR spectrum
9
. Figure 35A shows the 
proton peak of hydroxyl protons (c) at each end of the Pluronic
®
. The hydroxyl proton peak was 
disappeared in the NMR spectrum (Figure 35B) upon the activation of Pluronic
®
. In addition, the 
appearance of proton peak of the methylene group (f) at 4.45ppm confirmed the successful 
activation of the Pluronic
®
. 
 
Figure 34: Synthetic reaction scheme for the preparation of MMP-sensitive polymers from PEG-
PPG-PEG triblock copolymer (Pluronic
®
). 
Several peptide sequences such as GPLGIAGQ, GPQGPAGQ, PVGLIG, and CGLDD have 
shown MMP susceptibility
42,46,82
. An octapeptide sequence (GPVGLIGK-NH2) has been 
synthesized to conjugate to the Pluronic
®
 moiety. An MMP-sensitive hexapeptide (PVGLIG)
82
 
was modified at the ends with two amino acids (glycine and lysine) to provide amine functional 
groups on both ends. 
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Figure 35: 
1
H-NMR spectra of (A) Pluronic
® 
P104, (B) Activated Pluronic
®
 P104 and (C) 
MMP-P104. CDCl3 was used to measure the NMR spectra of all polymers. 
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The modification in the peptide would allow the conjugation reaction to the terminals while 
maintaining MMP-sensitive cleavage of the peptide at –GL– 99. The terminal amino groups of 
the peptide allowed the linear oligomerization between the peptide and NPC- Pluronic
®
.  
Table 5: Effect of different reaction conditions on the molecular weight of the final polymer. The 
Mn values represent mean ± SD for n=3. 
 
a
 Number average molecular weights determined by GPC 
b
 Polydispersities  based on GPC measurements 
 
The oligomerization was carried out for 24 h at room temperature. As Pluronic
®
 of molecular 
weight ~ 5000 may not be easily accessible for the oligomerizaion, the reaction time and 
temperature were increased to check the effect of these parameters on the final molecular weight 
of MMP-P104. Further, the final polymer was purified by dialysis using a regenerated cellulose 
membrane (6000-8000 Da) to remove unreacted Pluronic
®
 or peptide. Table 5 summarizes the 
molecular weights of MMP-P104 at different reaction conditions. The molecular weight of 
MMP-P104 slightly increased on increasing the reaction time and temperature. Figure 35C 
shows the 
1
H-NMR spectrum of MMP-P104. The oligomerization was confirmed by the 
Polymer Reaction conditions Mn (g/mol)
a
 Mw/Mn
b
 
1 RT (one day) 17570 (± 1060) 1.34 
2 RT (one day) + 50 
o
C (one day) 21120 (± 960) 1.47 
3 RT (one day) + 50 
o
C (two days) 23270 (± 1100) 1.33 
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characteristic proton peaks of peptide and Pluronic
®
 in the final polymer. The proton peaks at g 
to v shows the presence of peptide and its conjugation to Pluronic
®
. 
Table 6: Characterization of multiblock copolymers and triblock monomers. The Mn values 
represent mean ± SD for n=3. 
Polymer Mn(g/mol)
a
 Mw/Mn
b
 
Number of 
repeating units 
Tm (
o
C)
c
 
Pluronic
®
 P85 7410 (± 120) (4600
d
) 1.06  - 38.9 
Pluronic
®
 P104 8520 (± 110) (5900
e
) 1.05  - 39.4 
MMP-P85 15290 (± 920) 1.47 2.06 28.5 
MMP-P104 23540 (± 1100) 1.33 2.76 30.9 
 
a
 Number average molecular weights determined by GPC 
b
 Polydispersities  based on GPC measurements 
c  
Melting temperatures determined by DSC 
d,e
 Molecular weights from BASF chemical company 
 
Determined molecular characteristics of Pluronic
®
 copolymers, MMP-P85 and MMP-P104 were 
summarized in Table 6. The calculated molecular weights of MMP-P85 and MMP-P104 were 
found to be 15290 and 23540 g/mol respectively. The molecular weight analysis indicates that 
MMP-P85 and MMP-P104 are multiblock copolymers with 2.06 and 2.76 units of Pluronic
®
 P85 
and Pluronic
®
 P104 respectively. Comparing to previously reported Pluronic
®
-based multiblock 
copolymers
88
, multiblock copolymers with relatively low molecular weights were achieved 
because of relatively high molecular weight peptide (~740 g/mol) which might limit the access 
of the nitro group at the end of the Pluronic
®
 to the amine group in the peptide during 
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oligomerization. According to DSC data, the melting temperatures (Tm) of MMP-P85 and MMP-
P104 were found to be 28.5 and 30.9 
o
C. The Tm values of multiblock copolymers are lowered 
comparing to the Tm values of Pluronic
®
 monomers. This lowering of the Tm values of MMP-P85 
and MMP-P104 may be due to the interrupted polymer packing by the incorporation of a peptide 
in the polymer structure
88
. 
 
 
 
 
 
 
 
 
Figure 36: CMC determination of MMP-P104 using a dye solubilization method. The CMC is 
defined as the point of intersection of two exponential lines. The CMC of MMP-P104 was found 
to be 0.208 (±0.012) wt%. The CMC value represents the mean ±SD of three experiments. 
The relatively high molecular weight and acceptable gelation properties of MMP-P104 made this 
multiblock copolymer an interested candidate comparing to MMP-P85. So, the further 
characterization was mainly performed with MMP-P104. A hydrophobic dye solubilization 
method was used to measure the CMC of MMP-P104
88,89
. DPH is a hydrophobic molecule 
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which has strong absorbance at 344, 358 and 377nm. The absorbance of DPH greatly depends on 
the hydrophobicity of the local environment. DPH has low absorbance (377 nm) in an aqueous 
environment while it has high absorbance in hydrophobic environment. When DPH probe is 
mixed with micelle solution, it is trapped in the hydrophobic core of the micelle, and its 
absorbance will address the hydrophobic nature of the core. The absorbance of DPH has sharply 
increased at CMC of the MMP-P104 (Figure 36). The CMC was calculated by extrapolating the 
absorbance versus logarithmic concentration. The CMC of MMP-P104 was found to be 0.208 
(±0.012) wt% which is slightly lower than the CMC of Pluronic
®
 P104 (0.300 (±0.009) wt%). 
 
 
 
 
 
 
 
Figure 37: Determination of CMT of MMP-P104 solutions by DSC. The onset temperature of 
the endothermic peak represents the CMT of the solution. 
This lowering of the CMC is mainly attributed to the increased molecular weight of MMP-P104. 
This can be explained in two ways. First, at a given PPO/PEO ratio, higher molecular weight 
Pluronic
®
 polymers form micelles more readily than the lower molecular weight polymers
98
. 
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Second, the easy micelle formation is favored for multiblock copolymer as covalently bonded 
PPGs facilitate easy hydrophobic core formation during micelle structuring
89
. 
The polymer solutions were further characterized for CMT. The micellization process is 
characterized by endothermic peak during the heating cycle in DSC. Figure 37 shows the 
endotherms of all measured concentrations in the heating range 0 to 40 
o
C. The onset 
temperature at which micelles start to form is considered as the CMT at the particular polymer 
concentration. The CMT of Pluronic
® 
P104 solutions were found to be 23.35, 19.87, 16.96, 
14.54, 11.13 and 7.55 
o
C for 1, 5, 10, 15, 20 and 25 wt% respectively. The CMTs of MMP-P104 
were 22.65, 19.51, 16.77, 14.25, 10.93 and 5.78 
o
C for 1, 5, 10, 15, 20 and 25 wt% respectively. 
The trend in CMT changes with polymer concentration was in accordance with phase transition 
of Pluronic
®
 P104
98,100
. The CMT of MMP-P104 slightly lowered than that of Pluronic
®
 P104 at 
each polymer concentration. This is mainly due to the higher molecular weight of the multiblock 
copolymer comparing to Pluronic
®
 P104. High molecular weight block polymers are known to 
be more favorable for micelle formation than low molecular weight polymers
98
. 
Secondary structures of MMP-P104 and peptide in solution were analyzed using CD 
spectroscopy as a function of temperature. Formation of α- helices (one positive band centered at 
~ 195 nm and two negative bands between 205-225 nm) or β- sheets (one positive band centered 
at ~ 195 nm and one negative band between 210-220 nm) or random coils (one negative band 
centered at ~ 195 nm and one positive band centered at ~ 215 nm) will show characteristic CD 
spectra
81
. Spectra of both peptide and MMP-P104 suggested the random coil arrangement of 
MMP-sensitive peptide in the multiblock copolymer in an aqueous environment. Pluronic
®
 did 
not show a considerable effect on the random coil arrangement of peptide in water. Figure 38 
shows the CD spectra of MMP-P104 at 15, 25, 35 and 45 
o
C.  
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Figure 38: CD spectra of MMP-P104 at different temperatures. Molar ellipticity was plotted on 
the vertical axis. All the solutions showed a negative band at ~ 195 nm and a positive band at 
~215 nm. 
As the temperature increased, a considerable decrease in the negative band at 195 nm was 
observed. In addition, a small decrease in the positive band at 215 nm was also observed. This 
pattern indicates a slight change in the secondary structural arrangement of MMP-P104, 
suggesting the possibility of more ordered structures between peptides comparing to random 
coils with a temperature increment.  
Cytotoxicity of Pluronic
®
 P104 and MMP-P104 was assessed by MTT assay using HT1080 
fibrosarcoma cells. As HT1080 cells are known to express different types of MMPs, especially 
MMP 2 and 9, they were chosen for the assessment of the cytotoxicity
101,102
. 
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Figure 39 shows the results of MTT assay in the polymer concentration ranging from 0.05 to 
1.00 wt%. It is shown that MMP-P104 resulted in a greater cell viability comparing to 
monomeric Pluronic
®
 P104. 
 
 
 
 
 
 
 
 
Figure 39: Cell viability as a function of concentration was measured for Pluronic
®
 P104 and 
MMP-P104 on HT1080 cells. The results represent the mean ±SD for n=3. 
The difference in cytotoxicity can be attributed to molecular weight difference between MMP-
P104 and Pluronic
®
 P104. Previously, MBCP-2 of molecular weight ~ 40000 showed cell 
viability of >80%
88
. Therefore the increase in polymer molecular weight would be a vital means 
to improve the biocompatibility of MMP-P104. Biocompatible MMP-104 with increased 
molecular weight would provide an ideal cancer drug delivery platform which can achieve 
bioresponsive drug release as well as enhanced cytotoxicity to cancer cells with the sensitizing 
effect from released Pluronic
®
 P104. 
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The fundamental properties such as sol-gel and gel-sol transition temperatures of Pluronic
®
 P104 
and MMP-P104 polymer solutions were evaluated by test tube inverting method and falling ball 
method. Figure 40 shows the phase diagram of MMP-P104 and Pluronic
®
 P104 at different 
polymer concentrations.  
 
 
 
 
 
 
 
Figure 40: Phase diagrams of Pluronic
®
 P104 and MMP-P104 aqueous solutions constructed 
by both test tube inverting method and falling ball methods. The results represent mean ±SD for 
n=3. 
The sol-gel transition temperatures determined by test tube inverting method are in good 
agreement with the values determined by falling ball method. Due to an extended equilibration 
time during the execution of falling ball method, a slight difference in gelation temperature was 
observed between two methods. At all polymer concentrations tested for gelation, MMP-P104 
solutions were free flowing liquids at room temperature which could be easily injected through 
25-guage needle. Upon increasing the temperature to 37 
o
C, the solution immediately turned into 
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gel depending on the polymer concentration. Figure 41 shows the change in viscosities with 
temperature of MMP-P104 solutions at different polymer concentrations. 
 
 
 
 
 
 
 
Figure 41: Dynamic viscosity measurement of MMP-P104 solutions as a function of 
temperature. Dynamic viscosity was measured using falling ball method for different polymer 
concentrations. 
The viscosities are below 500 g/cm.sec
-1 during the “sol” state where as they ranged between 
1000-9000 g/cm.sec
-1
 during the “gel” phase for all the measured concentrations. MMP-P104 
solutions showed sol-gel-sol transition in the range of 10-25
 
wt%. But, the Pluronic
®
 P104 (25 
wt%) solution showed sol-gel-sol-gel-sol transition on increasing the temperature. Formation of 
isotropic or cubic crystalline phases is responsible for gelation at low temperature whereas 
formation of multi-phases (cubic/hexagonal/lamellar) cause gelation at high temperature
104
. The 
sol-gel transition temperatures of MMP-P104 were lowered comparing to Pluronic
®
 P104 at 
particular concentration. 
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Figure 42: GPC chromatographs showing MMP-P104 polymer degradation in presence or 
absence of MMP. The multiblock copolymers were degraded into lower molecular weight 
monomers. At 0 h, a small amount of unreacted Pluronic
® 
P104 was detected in the 
chromatographs of MMP-P104. 
For example, at 25 wt% the gelation temperature of Pluronic
®
 P104 was 68.5 
o
C whereas the 
gelation temperature of MMP-P104 was 30.7 
o
C. In addition to the sol-gel transition, the CGC of 
MMP-P104 was also lowered comparing to the CGC of Pluronic
®
 P104. This lowering of CGC 
and sol-gel transition temperatures was mainly attributed to the extended and enforced chain 
entanglements due to increased molecular weight in MMP-P104 comparing to Pluronic
®
 P104. 
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Figure 42 shows the GPC chromatographs of degraded MMP-P104 in presence or absence of 
MMP. An MMP concentration of 250 µg/mL was chosen to study the polymer degradation in a 
facilitated condition. MMP-P104 degraded rapidly in presence of MMP showing complete 
polymer degradation within 24 h while the polymer degraded much slower in the absence of 
MMP. Complete polymer degradation was observed at the end of day 12 without the enzyme. 
GPC was also run on Pluronic
®
 P104 to compare the changes in chromatographs. The 
chromatograph of completely degraded MMP-P104 was similar to that of Pluronic
®
 P104 
indicating that the multiblock copolymer degraded into its monomeric units. Considering the 
MMP-cleavable site in the peptide, the possible degradation products of multiblock copolymer 
would be the Pluronic
® 
monomers with four amino acids on both the terminals. However, 
remaining peptide segments will be eventually degraded into amino acids by proteases in the 
body. 
MMP-P104 solutions demonstrated quick gelation which occurred within a minute below body 
temperature at a polymer concentration of 25 wt%. Based on this observation, 25 wt% was 
selected for in vitro PTX release. The achieved PTX concentration in 25 wt% MMP-P104 
solution was found to be 0.850 mg/mL. The achieved PTX concentration was a 200-fold increase 
in PTX solubility in water with a PTX concentration change from 0.004 mg/mL to 0.850 mg/mL 
in the presence of the polymer. PTX and CPT release from the MMP-sensitive thermogel was 
investigated at different MMP concentrations as well as in MMP free media. Release profiles 
have been summarized in Figure 43 and 44. PTX release lasted for 2, 5 and 8 days at MMP 
concentrations of 50, 10, and 1 µg/mL, respectively. In addition, CPT released quickly in 1 day 
at 250 µg/mL of MMP. Rapid drug release due to the erosion of the gels was observed in 
presence of MMP. Based on the consistency between PTX release and polymer degradation, it is 
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notable that erosion played a main role in the drug release in presence of MMP. On the other 
hand, both erosion and diffusion have caused sustained drug release up to 13 days in the absence 
of MMP. 
 
 
 
 
 
 
 
 
Figure 43: PTX release at different MMP concentrations such as 0, 1, 10 and 50 µg/mL. The 
results represent mean ±SD for n=3. 
 
 
 
 
 
 
 
 
 
Figure 44: CPT release at 0 and 250 µg/mL of MMP. The results represent mean ±SD for n=3. 
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Figure 45: PTX release from MMP-P104 thermogels with an alterating challenge of MMP free 
medium following MMP containing medium. The addition of MMP in the release medium at a 
concentration of 250 µg/mL triggered a fast drug release. The results represent mean ±SD for 
n=3. 
Precise drug release from an in-situ formed hydrogel depot to achieve a local therapeutic drug 
concentration is a difficult task since there is no viable mechanism to control drug release once it 
forms a depot. The hydrogel depot is expected to monotonously release incorporated drug at a 
predetermined rate until incorporated drug is completely exhausted. The presence of an extra 
mechanism that is able to control drug release even beyond in-situ depot formation and secure a 
therapeutic level of drug will be highly desirable for successful local drug delivery particularly 
for detrimental diseases such as cancers.  MMP-sensitive thermogels were tested for cooperative 
drug release by diffusion and enzymatic hydrogel degradation which may be useful for the 
achievement of effective local drug delivery potentially for cancers. The thermogel was 
challenged with an alternating medium change to simulate an MMP-elevation in cancer. As 
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shown in Figure 45, the thermogel immediately increased PTX release upon a medium 
replacement from MMP-free medium to MMP-containing medium. Upon an addition of MMP at 
a concentration of 250 µg/mL, cumulative PTX release was dramatically increased from 27% to 
complete drug release within 24 hr. The MMP-sensitive drug release demonstrated in Figures 43, 
44 and 45 is completely in accordance with the polymer degradation presented in Figure 42.  
Marked increase in drug release from the MMP-sensitive thermogel suggests the capability of 
MMP-sensitive thermogel as a bioresponsive local drug delivery platform which would be 
particularly applicable for cancer drug delivery.  
5.5. Conclusions 
MMP-sensitive thermogelling polymers have been successfully synthesized for potential drug 
delivery applications by incorporating an MMP-sensitive peptide into an amphiphilic multiblock 
copolymer. The aqueous solution of the synthesized polymer underwent gelation at body 
temperature. In addition, the gelation temperature of the polymer solutions varied depending on 
the polymer concentration. The cytotoxicity of the synthesized polymer was lower comparing to 
the corresponding monomer. The polymer was rapidly degraded in presence of MMP. The 
synthesized polymer greatly enhanced the solubility of hydrophobic cancer drugs, PTX and CPT. 
The polymer gels exhibited the release of incorporated drug in a bioresponsive manner. 
“Reprinted from Acta Biomaterialia, 7, Garripelli VK, Kim JK, Son S, Kim WJ, Repka MA, Jo 
S, Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug 
delivery, 1984-1992, Copyright (2011), with permission from Elsevier Limited.” 
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CHAPTER-6 
CONCLUSIONS 
Thermosensitive hydrogels have already been successfully employed in various 
biomedical applications. The unique properties of these systems greatly influence the future of 
biomaterials, especially in the fields of controlled drug delivery and tissue engineering. In the 
current research work, two bioresponsive thermogelling systems based on multiblock 
copolymers were succesfully developed. The multiblock copolymers were synthesized from 
amphiphilic triblock copolymers, Pluronic
®
 P85 and P104. The thermogelling polymers were 
synthesized for local drug delivery applications by incorporating responsive moieties (pH-
responsive and MMP-responsive) into the multiblock copolymers. The structural and 
physicochemical characterization of the synthesized polymers was successfully completed by 
different techniques such as NMR, GPC, CD, DSC, etc. The aqueous solutions of the polymers 
showed concentration dependent gelation. Most importantly, the polymer solutions underwent 
gelation at body temperature (37 °C). The synthesized polymers showed either minimum or no 
cytotoxicity indicating that the thermogelling systems are biocompatibile. In addition to the two 
thermosensitive polymers, a NCT has been developed and characterized for sustained delivery of 
small proteins. Finally, the ability of the thermogels to manipulate the drug release shows that 
the current thermogel and NCT systems hold great potential for controlled drug delivery. 
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